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A B S T R A C T 
Human blood contains several inhibitors of 
proteolytic enzymes which arc implicated in the 
regulation of physiological processes such as blood 
coagulation, complement fixation and response to 
inflammation. These inhibitors exert their regulatory 
functions by maintaining a proper proteinase-proteinase 
inhibitor equilibrium in the tissue. Alpha-j^-antichymo-
trypsin is one of the important human plasma/ serum 
inhibitor which inhibits serine proteinases. In view of 
the desirability of getting relevant informations on 
alpha,-antichymotrysin from mammals other than human and 
the fact that inhibitor was found to be absent in certain 
mammalian serum e.g. porcine, it was thought worthwhile 
to isolate and characterize the inhibitor from hitherto 
uninvestigated source i.e. goat. 
Goat chymotrypsin inhibitor was isolated both 
from serum and plasma and their properties were found to 
be indistinguishable. Goat plasma showing 5% inhibitory 
activity per milligram of protein was salt fractionated 
and further purified by ion exchange chromatography on 
DEAE-cellulose column (2.4 x 6.0 cm ) equilibrtStedL with 
10 mM sodium phosphate buffer, pH 7.5 ^  containing 50 mM 
NaCl and 0.02% sodium azide. The protein was eluted 
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batchwise with the buffer containing varying 
concentrations of sodium chloride (0.1 M - 0.2M NaCl). 
The protein fractions eluted with the buffer containing 
150 mM sodium chloride, showing optimal antichymotryptic 
activity/ were pooled and rechromatographed on the same 
ion exchange column. The final protein yield of the 
inhibitor was 0.15% (W/W). Thus about 80 mg of the pure 
inhibitor was isolated from the goat plasma containing 53 
g of protein by the procedure used in this study. 
The goat inhibitor preparation moved 
essentially as a single protein band in 12% 
polyacrylamide gel during electrophoresis performed in 
Tris glycine buffer ( 25 mM Tris and 194 mM glycine), pH 
8.3, containing 0.1% SDS with a -relative mobility of 
0.26. This showed that the preparation of goat 
c motrypsin inhibitor obtained in this study was homoge-
neous with respect to size. The size homogeneity was 
also indicated by gel filtration on Sephadex G-200 
column to be described below. 
When the measured relative mobility (0.26) of 
the chymotrypsin inhibitor was compared with the relative 
mobilities of marker proteins viz, transferrin, bovine 
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serum albumin, Ig G, ovalbumin, chymotrypsinogen A and 
cytochrome £ which were electrophoresed under conditions 
identical to that used for the electrophoresis of the 
inhibitor, the molecular weight of the inhibitor was 
found to be 68 kDa. The observation that relative 
mobiliity of the chymotrypsin inhibitor remained 
unaltered under reducing (0.02 M 2-mercaptoethanol) and 
nonreducing conditions taken together with the conclusion 
that the native molecular weight (76 kDa) as determined 
by gel filtration suggested that the inhibitor consisted 
of a single polypeptide chain. The native molecular 
weight ( 76 kDa) as determined by gel filtration under 
native condition is about 12% higher than that ( 68 kDa) 
determined by polyacrylamide gel electrophoresis under 
denaturing conditions. The discrepancy has been ascribed 
to the glycoprotein nature of the inhibitor. 
Goat chymotrypsin inhibitor was found to be a 
sialoglycoprotein containing 4.5% sialic acid and 12% 
neutral hexose; these results would mean that the 
« 
inhibitor molecule contains 10 moles of sialic acid and 
47 moles of neutral hexose. 
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The number of free sulfhydryl group in the goat 
chymotrypsin inhibitor was determined by titration with 
p-hydroxymercuriben^oate in 10 mM sodium phosphate buffer, 
pH 7.0. From the curve between increase in absorbance at 
250 nm and molar ratio of p-hydroxymercuribenzoate to 
inhibitor, the number of free sulfhydryl group per mole 
of inhibitor was calculated as one. Interestingly, the 
goat chymotrypsin inhibitor with sulfhydryl group blocked 
with p-hydroxymercuribenzoate retained its full antichy-
motryptic activity suggesting that the lone titrable 
sulfhydryl group in the inhibitor had no functional role. 
The isoionic preparation of goat chymotrypsin 
inhibitor was prepared by passing extensively dialyzed 
inhibitor solution through Dintzis column. The pH of the 
inhibitor solution containing 1.6 mg/ml protein was 
determined to be 5.5. The concentration of isoionic 
inhibitor solution was measured by dry weight method. 
The goat inhibitor solution ( 0.11 mg/ml ) absorbed 
: aximally at 278 nm in 10 mM sodium phosphate buffer, pH 
7.5, containing 150 mM sodium chloride. Fluorescence 
excitation and emission spectra of the goat inhibitor 
were obtained in the same buffer but at relatively lower 
protein concentration (0.02 mg/ml). The emission and 
-4-
and excitation maxima were found to occur near 338 and 
278 nm, respectively. These spectral features suggest 
that inhibitor is a tryptophan containing protein. 
The specific extinction coefficient of goat 
chymotrypsin inhibitor was computed from the measured 
optical densities of protein solutions of known 
concentrations .. The values of specific extinction 
2 -1 
coefficient were found to be 6.23 and 5.92 cm g 
respectively at 278 and 280 nm. 
The hydrodynamic properties of chymotrypsin 
inhibitor were studied by analytical gel chromatography on 
a Sephadex G-200 column (2.4 x 78 cm) equilibrated with 
10 mM sodium phosphate buffer, pH 7,5, containing 150 mM 
sodium chloride and 0.02% sodium azide. The column was 
calibrated with marker proteins of known molecular weights 
and Stokes radii. These were bovine serum albunim, 
ovalbumin, pepsin, chymotrypsinogen A and cytochrome £. 
The elution volume of the goat chymotrypsin inhibitor from 
the column was measured to be 202 ml which would correspond 
to a molecular weight of 76 kDa and Stokes' radius of 3.53 
nm. The Stokes radius of the inhibitor was used in 
the calculation of its diffusion coefficient and fric-
_7 
tional ratio which were found to be 6.29 x 10 
-5-
cm / sec and 1.32, respectively. Thus the measured 
frictional ratio (1.32) is significantly different than 
that expected for a globular protein. Alternatively this 
may be due to unusually high degree of hydration of the 
goat sialoglycoprotein chymotrypsin inhibitor containing 
as high as 17% carbohydrate. 
The thermal stability of the goat chymotrypsin 
inhibitor was studied in 10 mM sodium phosphate buffer, 
pH 7.5, containing 150 mM sodium chloride in the 
temperature range, 37 -60 C. The inhibitor was kept at a 
given temperature for 15 minutes and its inhibitory 
activity was measured against bovine chymotrypsin at 37 C. 
The inhibitor incubated at 37 C and 45 C showed the same 
inhibitory activity. However, by treatment of the 
inhibitor at 50 C and 55 C, the losses in inhibitory 
activity were 35% and 65% respectively. When the 
inhibitor was incubated at 60 C for 15 minutes and its 
inhibitory activity was measured, no activity was 
detected suggesting the inactivation of the inhibitor at 
60°C. 
Unlike human alpha-,-antichymotrypsin the goat 
chymotrypsin inhibitor was able to inhibit even trypsin 
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at relatively higher inhibitor concentration. Thus under 
identical conditions complete inactivation of 
chymotrypsin was achieved at inhibitor to enzyme molar 
ratio of 1.1. However, with trypsin this ratio increased 
to 4.5. For time course studies chymotrypsin and trypsin 
were treated with the goat chymotrypsin inhibitor at a 
molar ratio ([1]/[E]) of 1.1 and 5.0 respectively in 10 
mM sodium phosphate buffer, pH 7.5. containing 150 mM 
sodium chloride. The residual caseinolytic activity of 
the mixture was measured at different time intervals. 
The inhibition of chymotrypsin was completed within 5 
minutes, however,as much as 50 minutes were required to 
achieve complete inhibition of the caseinolytic activity 
of trypsin. This observation suggests that the goat 
chymotrypsin inhibitor inhibited chymotrypsin in a biolo-
gically feasible time while inhibition of trypsin by the 
inhibitor appeared to have little or no biological 
significance. From the time course of inactivation of 
.chymotrypsin by the goat inhibitor, the rate constant for 
the association of the inhibitor with the enzyme was 
calculated to be 1.6 x 10 M s at 37 C which is 
comparable to that found for human inhibitor 
chymotrypsin system. 
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A B S T R A C T 
Human blood contains several inhibitors of 
proteolytic enzymes which arc implicated in the 
regulation of physiological processes such as blood 
coagulation, complement fixation and- response to 
inflammation; These inhibitors exert their regulatory 
functions by maintaining a proper proteinase-proteinase 
inhibitor equilibrium in the tissue. Alpha-j^-antichymo-
trypsin is one of the important human plasma/ serum 
inhibitor which inhibits serine proteinases. In view of 
the desirability of getting relevant informations on 
alpha,-antichymotrysin from mammals other than human and 
the fact that inhibitor was found to be absent in certain 
mammalian serum e.g. porcine, it was thought worthwhile 
to isolate and characterize the inhibitor from hitherto 
uninvestigated source i.e. goat. 
Goat chymotrypsin inhibitor was isolated both 
from serum and plasma and their properties were found to 
be indistinguishable. Goat plasma showing 5% inhibitory 
activity per milligram of protein was salt fractionated 
and further purified by ion exchange chromatography on 
DEAE-cellulose column (2.4 x 6.0 cm ) equilib-v-aiea. with 
10 mM sodium phosphate buffer, pH 7.5^ containing 50 mM 
NaCl and 0.02% sodium azide. The protein was eluted 
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batchwise with the buffer containing varying 
concentrations of sodium chloride (0.1 M - 0.2M NaCl). 
The protein fractions eluted with the buffer containing 
150 mM sodium chloride, showing optimal antichymotryptic 
activity, were pooled and rechromatographed on the same 
ion exchange column. The final protein yield of the 
inhibitor was 0.15% (W/W) . Thus about 80 mg of the pure 
inhibitor was isolated from the goat plasma containing 53 
g of protein by the procedure used in this study. 
The goat inhibitor preparation moved 
essentially as a single protein band in 12% 
polyacrylamide gel during electrophoresis performed in 
Tris glycine buffer ( 25 mM Tris and 194 mM glycine), pH 
8.3, containing 0.1% SDS with a relative mobility of 
0.26. This showed that the preparation of goat 
chymotrypsin inhibitor obtained in this study was homoge-
neous with respect to size. The size homogeneity was 
also indicated by gel filtration on Sephadex G-200 
column to be described below. 
When the measured relative mobility (0.26) of 
the chymotrypsin inhibitor was compared with the relative 
mc'-^ ilities of marker proteins viz, transferrin, bovine 
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serum albumin, Ig G, ovalbumin, chymotrypsinogen A and 
cytochrome £ which were electrophoresed under conditions 
identical to that used for the electrophoresis of the 
inhibitor, the molecular weight of the inhibitor was 
found to be 68 kDa. The observation that relative 
mobiliity of the chymotrypsin inhibitor remained 
unaltered under reducing (0.02 M 2-mercaptoethanol) and 
nonreducing conditions taken together with the conclusion 
that the native molecular weight (76 kDa) as determined 
by gel filtration suggested that the inhibitor consisted 
of a single polypeptide chain. The native molecular 
weight ( 76 kDa) as determined by gel filtration under 
native condition is about 12% higher than that ( 68 kDa) 
determined by polyacrylamide gel electrophoresis under 
denaturing conditions. The discrepancy has been ascribed 
to the glycoprotein nature of the inhibitor. 
Goat chymotrypsin inhibitor was found to be a 
sialoglycoprotein containing 4.5% sialic acid and 12% 
neutral hexose; these results would mean that the 
inhibitor molecule contains 10 moles of sialic acid and 
47 moles of neutral hexose. 
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The number of free sulfhydryl group in the goat 
chymotrypsin inhibitor was determined by titration with 
p-hydroxymercuribonzoate in 10 mM sodium phosphate buffer, 
pH 7.0. From the curve between increase in absorbance at 
250 nm and molar ratio of p-hydroxymercuribenzoate to 
inhibitor, the number of free sulfhydryl group per mole 
of inhibitor was calculated as one. Interestingly, the 
goat chymotrypsin inhibitor with sulfhydryl group blocked 
with p-hydroxymercuribenzoate retained its full antichy-
motryptic activity suggesting that the lone titrable 
sulfhydryl group in the inhibitor had no functional role. 
The isoionic preparation of goat chymotrypsin 
inhibitor was prepared by passing extensively dialyzed 
inhibitor solution through Dintzis column. The pH of the 
inhibitor solution containing 1.6 mg/ml protein was 
determined to be 5.5. The concentration of isoionic 
inhibitor solution was measured by dry weight method. 
The goat inhibitor solution ( 0.11 mg/ml ) absorbed 
maximally at 278 nm in 10 mM sodium phosphate buffer, pH 
7.5, containing 150 mM sodium chloride. Fluorescence 
excitation and emission spectra of the goat inhibitor 
were obtained in the same buffer but at relatively, lower 
protein concentration (0.02 mg/ml). The emission and 
-VI-
and excitation maxima were found to occur near 338 and 
278 nm, respectively. These spectral features suggest 
that inhibitor is a tryptophan containing protein. 
The specific extinction coefficient of goat 
chymotrypsin inhibitor was computed from the measured 
optical densities of protein solutions of known 
concentrations . The values of specific extinction 
2 -1 
coefficient were found to be 6.23 and 5.92 cm g 
respectively at 278 and 280 nm. 
The hydrodynamic properties of chymotrypsin 
inhibitor were studied by analytical gel chromatography on 
a Sephadex G-200 column (2.4 x 78 cm) equilibrated with 
10 mM sodium phosphate buffer, pH 7.5, containing 150 mM 
sodium chloride and 0,02% sodium azide. The column was 
calibrated with marker proteins of known molecular weights 
and Stokes radii. These were bovine serum albunim, 
ovalbumin, pepsin, chymotrypsinogen A and cytochrome £. 
The elution volume of the goat chymotrypsin inhibitor from 
the column was measured to be 202 ml which would correspond 
to a molecular weight of 76 kDa and Stokes radius of 3,53 
nm. The Stokes radius of the inhibitor was used in 
the calculation of its diffusion coefficient and fric-
_7 
tional ratio which were found to be 6.29 x 10 
-vii-
cm / sec and 1.32, respectively. Thus the measured 
frictional ratio (1.32) is significantly different than 
that expected for a globular protein. Alternatively this 
may be due to unusually high degree of hydration of the 
goat sialoglycoprotein chymotrypsin inhibitor containing 
as high as 17% carbohydrate. 
The thermal stability of the goat chymotrypsin 
inhibitor was studied in 10 mM sodium phosphate buffer, 
pH 7.5, containing 150 mM sodium chloride in the 
temperature range, 37 -60 C. The inhibitor was kept at a 
given temperature for 15 minutes and its inhibitory 
activity was measured against bovine chymotrypsin at 37 C. 
The inhibitor incubated at 37 C and 45 C showed the same 
inhibitory activity. However, by treatment of the 
inhibitor at 50 C and 55 C, the losses in inhibitory 
activity were 35% and 65% respectively. When the 
inhibitor was incubated at 60 C for 15 minutes and its 
inhibitory activity was measured, no activity was 
detected suggesting the inactivation of the inhibitor at 
60°C. 
Unlike human alpha-,-antichymotrypsin the goat 
chymotrypsin inhibitor was able to inhibit even trypsin 
-viii-
at relatively higher inhibitor concentration. Thus under 
identical conditions complete inactivation of 
chymotrypsin was achieved at inhibitor to enzyme molar 
ratio of 1.1. However, with trypsin this ratio increased 
to 4.5. For time course studies chymotrypsin and trypsin 
were treated with the goat chymotrypsin inhibitor at a 
molar ratio ([1]/[E]) of 1.1 and 5.0 respectively in 10 
mM sodium phosphate buffer, pH 7.5. containing 150 mM 
sodium chloride. The residual caseinolytic activity of 
the mixture was measured at different time intervals. 
The inhibition of chymotrypsin was completed within 5 
minutes, however,as much as 50 minutes were required to 
achieve complete inhibition of the caseinolytic activity 
of trypsin. This observation suggests that the goat 
chymotrypsin inhibitor inhibited chymotrypsin in a biolo-
gically feasible time while inhibition of trypsin by the 
inhibitor appeared to have little or no biological 
significance. From the time course of inactivation of 
.chymotrypsin by the goat inhibitor, the rate constant for 
the association of the inhibitor with the enzyme was 
calculated to be 1,6 x 10~ M~ s~ at 37°C which is 
comparable to that found for human inhibitor 
chymotrypsin system. 
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ISOLATION AND CHARACTERIZATION OF SERUM 
CHYMOTRYPSIN INHIBITOR 
INTRODUCTION 
Proteinase inhibitors exist in multiple forms 
in numerous tissues of animals (Laskowaski and Kato,1980) 
Their main function appears to be prevention of unwanted 
proteolysis, however, the exact function of a particular 
inhibitor is not always known with precision. Many 
proteolytic processes such as blood coagulation, blood 
clot dissolution, hormone production or elimination and 
complement fixation occur in blood and require exquisite 
control. In vitro proteolytic activities can be 
regulated by changing pH, temperature, ionic strength and 
enzyme and substrate concentrations, however, such 
variables can not operate to control the kinetic 
equilibria in vivo. Therefore, to control proteolytic 
activities in vivo a large number of proteinase 
inhibitors are present in plasma. Proteinase inhibitors 
were detected in human plasma as far as back in 1894 by 
Fermi and Pernossi. These inhibitors constitute about 
10% of the total plasma proteins (Bodmer and Schnebli, 
1984) and form, by weight, the third major component of 
the functional plasma proteins; the other two being 
albumin and immunoglobulins { Travis and Salvesen, 1983). 
-2-
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The proteinase inhibitors isolated and characterized from 
human plasma are listed in Table I. All these inhibitors 
are glycopeptide in nature with their molecular weights 
ranging from 54,000-725,000. The inhibitor preparations 
from plasma and serum are indistinguishable in their 
molecular and physical properties. These inhibitors 
differ miainly in their target specificity. Among these, 
C^jj M inhibits the majority of plasma proteinases from all 
four catalytic classes of enzymes - serine, cysteine, 
aspartic and metallo proteinases,while other inhibitors 
are class specific. Alpha,-antichymotrypsin*, Od-, - PI, 
Cl-Inh, AT III and loci inhibit only serine proteinases, 
Oi-CPI inhibits only cysteine proteinases and /3 -, -AC 
inhibits only collagenolytic enzymes of metalloenzyme 
class ( Travis and Salvesen, 1983). 
The same enzyme may be inhibited by more than 
one inhibitor and each inhibitor can inhibit the activity 
of more than one enzyme although with varying specificity 
and avidity. This extraordinary cross coverage serve as 
* In case of goat the proteinase inhibitor acting on 
bovine chymotrypsin has been referred to as chymotrypsin 
inhibitor. 
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TABLE I 
PROTEINASE INHIBITORS PRESENT IN HUMAN PLASMA 
Ncime 
Alpha-, -antichymotrypsin 
Alpha,-proteinase inhibitor 
Antithrombin - III 
Alphap-macroglobulin 
Inter - alpha - trypsin 
inhibitor 
CI - inhibitor 
Alpha„-antiplasmin 
Beta,-anticollagenase 
Alpha-cysteine 
proteinase inhibitor 
Molecular 
weight 
68,000 
55,000 
62,000 
725,000 
160 ,000 
105,000 
67,000 
30,000-
33,000 
57,000-
175,000 
Concentration 
g/litre 
0.5 
1.3 
0.29 
2.5 
0.5 
0.18 
0 07 
"~ 
-
M 
7.7 
23,6 
4.7 
3.5 
3.1 
1.7 
1.1 
— 
-
References:- ^ Harpel and Brower (1983) 
Travis and Salvesen (1983) 
a backup safety system especially in those cases where 
principal inhibitor is depleted or absent either congeni-
tally or in an acquired way ( Murano, 1985). The 
spectrum of inhibition of the various inhibitors is 
summarized in Table II. Accordingly it is difficult to 
identify the target enzyme for a particular inhibitor, 
however, the usual criteria to identify the target enzyme 
is to study the rate of complex formation of the 
inhibitor with suspected enzymes. The enzyme which 
reacts faster with inhibitor will probably be the target 
enzyme. This, together with the knowledge of the 
distribution of enzyme among all the inhibitors in 
plasma, would substantially reduce the false 
interpretations with regard to the specific role of a 
particular inhibitor. However, by using the formula 
given by Beith (1980), it is possible to measure in vivo 
half time of inhibition as follows--
t, , ^ 1/k [I] (1) 
h ass ass 
where k is the second order rate constant 
ass 
for association of inhibitor and enzyme and [I] is the 
normal concentration of inhibitor in plasma. 
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The half time of association in vivo of some of 
the proteinases with human plasma proteinase inhibitors 
are listed in Table III. For an inhibitor to have 
effective control of a particular enzyme, tj should 
-^  a s s 
not be more than 10 milliseconds (Travis and Salvesen, 
1983). But there are few exceptions e.g. interaction of 
Cl-Inhibitor with CIr or CIs which probably do not 
represent true in vivo rates because the en2yme(s) is in 
a multicomplex. The same is also true for kallikrein and 
Factor Xa. In addition to this there may be some other 
undiscovered factors in plasma or tissue that increases 
the rate of inhibition as heparin activates AT III 
(Travis and Salvesen, 1983). The physiological role for 
the inhibitor can be ascertained if an inhibitor is 
congenitally deficient in an individual with the 
development of a disease e.g. in case of 
alpha-,-proteinase inhibitor deficiency. But the 
deficiency states for all the inhibitors have not been 
reported so far ( Travis and Salvesen, 1983). 
Thus to assign a physiological function to an 
inhibitor, we should know — (i) physical defect 
associated with its deficiency, (ii) association constant 
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of interaction of inhibitor with enzyme and (iii) the 
partitioning of the enzyme in question among all plasma 
proteins. If the deficiency state is not known, the last 
two sets of data will still help in determining whether 
the inhibition of an enzyme by an inhibitor is rapid 
enough to be of physiological significance or not ( Travis 
and Salvesen, 1983) . 
Alpha-,-Antichymotrypsin: 
Alpha-,-antichymotrypsin described first by 
Schultze et al., (1962a) was isolated from human serum and 
partially characterized without knowing its function 
(Schultze et al., 1962b). Heimburger and Haupt (1965) 
demonstrated for the first time that this inhibitor causes 
inhibition of chymotryptic activity only and had no effect 
on activities of trypsin and plasmin. On electrophoresis 
of serum proteins the inhibitor was found to be localized 
in OcT fraction, accordingly it was termed as alpha-.-anti-
chymotrypsin . 
Alpha-]-antichymotrypsin is mainly synthesized in 
hepatocytes (Knowles et al., 1980) and the normal level of 
the inhibitor in plasma/serum ranges from 25 . to 60 mg/100 
ml(Heimburger, 1975; Travis and Salvesen, 1983). The 
-12-
inhibitor level shows dependence on age; lower values were 
found in children and the level increased with increase in 
age { Weeke and Krasilnikoff, 1972). In adults no 
concentration difference was found due to sex (Ganrot, 
1972; Kelly et al., 1978). The other body fluids having 
alpha-,-antichymotrypsin included urine { Bjerrum and Bog-
Hansen, 1975), pleural fluid (Laine and Hayem, 1981), 
aminiotic fluid (Bhat and Pattabiraman, 1980), seminal 
plasma (Schill, 1976), sol phase of sputum (Ryley and 
Brogan,1973), milk (Lindberg,1979), gastric juice, bile, 
cerebrospinal and synovial fluid (Kawaguchi et al. , 1983). 
By specific staining a number of cells were found to 
contain alpha-,-antichymotrypsin (Motoi et al. , 1980; 
Papadimitriou et al. , 1980). These cells among others 
included mast cells, endothelial cells, epithelioid cells 
and hepatoma cells. Platelets, Lymphoid cells such as T 
& 5 lymphocytes and myeloid cell line including myelocytes, 
neutrophils, basophils etc. were found to be devoid of 
inhibitor. Thus demonstration of alpha,-antichymotrypsin 
in /on the cells can be used as a marker for the origin of 
a particular cell line (Berninger,1985). 
Alpha,-antichymotrypsin is an early stage acute 
phase protein (Aronsen et al., 1972) as its plasma 
-13-
concentration has boon found to increase about two to four 
times of its basal level (Laurell,1972)within eight hours of 
tissue damage like surgery (Aronson et al., 1972; lllorl ct 
al., 1986), burn injuries (Coombes et al., 1979; Daniels et 
al., 1974; Moody et al. , 1985)^ Crohn's disease, ulcerative 
colitis (Weeke and Jarnum, 1971;Chambers et al., 1987) and 
myocardial infarction (Johansson et al. , 1972). Thus the 
inhibitor might have an important role in protection of 
body tissue from the damage caused by chymotrypsin like 
enzymes particularly those released during an inflammatory 
episode. As alpha-,-antichymotrypsin interacts most rapidly 
with cathepsin G which is involved in the hydrolysis of 
proteoglycan ( Roughley and Barrett, 1977), elastase, 
collagen (Justice et al. , 1987), fibronectin (Vartio et 
al. , 1981) and in the conversion of angiotensin I to 
biologically active fragment (Gaffer et al., 1980; Wintroub 
et al., 1981; Reilly et al. , 1982; Tonnesen et al. , 1982), 
some vital regulatory roles are proposed for this inhibitor. 
Alpha-, -antichymotrypsin was frequently detected 
in tumour cell nuclei of human stomach .,breast and pancreas 
adenocarcinoma and hepatoma (Takada et al., 1982; Ordonez 
and Manning, 1984; Tahara et al., 1984). Takada et al., 
(1986) have further observed that alpha-.-antichymotrypsin 
was not synthesized by carcinoma cells but was incorporated 
-14-
from blood circulation. Alpha-j^-antichymotrypsin was also 
found to inhibit DNA polymerase a (Tsuda et al., 1986; 
1987;Takada et al.,1988) and thus by inhibiting the DNA 
replication alpha-,-antichymotrypsin present in carcinoma 
cell may play some important role in host defence mechanism 
against tumour growth. Alpha,-antichymotrypsin also has an 
immunoenhancing effect on in vivo response to sheep RBCs in 
mice (Matsumoto et al., 1981; 1982a). On the other hand it 
was reported to inhibit human natural cytotoxicity 
(Katunuma et al. , 1978; Hudig et al. , 1981). Gravagna et 
al. , (1982) reported that alpha-,-antichymotrypsin inhibited 
both natural killing (NK) and antibody dependent cell 
mediated cytotoxicity (ADCC). This inhibition is resulted 
through the binding of the inhibitor on the NK and ADCC 
target cells and thus neutralizing the lytic signal passed 
between the effector and target. 
1. Isolation: 
Alpha,-antichymotrypsin has been isolated from 
human serum or plasma on several occasions. The methods 
usually included salt fractionation, gel filtration, ion 
exchange chromatography and affinity chromatography (Travis 
et al., 1978b: Siddiqui et al., 1980, Katsunuma et al., 
1980; Laine & Hayem, 1981; Abdullah et al. , 1983; Laine et 
-15-
al.,1984b; Yi et al., 1987). The ion exchange resins 
generally used were strong anion exchanger such as QAE -
Sephadex (Siddiqui et al., 1980; Abdullah et al., 1983) and 
weak anion exchanger like DEAE - Sephadex (Katsunuma et 
al., 1980). To remove albumin Cibacron Blue Sepharose 
(Travis et al., 1978b) and anti-albumin Sepharose (Laine 
and Hayem, 1981; Laine et al., 1984b) were used. Thiopro-
pyl-Sepharose and Thiol-Sepharose columns were used for its 
isolation because alpha,-antichymotrypsin does not bind to 
either column whereas many other serum proteins do (Laine 
and Hayem, 1981). By exploiting its property to bind 
DNA,.DNA- cellulose chromatography was also used for its 
isolation (Katsunuma et al. , 1980; Siddiqui et al., 1980; 
Abdullah et al., 1983; Yi et al. , 1987). Anti -
alpha, -antichymotrypsin antibody also has been used to 
prepare affinity gel (Laine and Hayem, 1981; Laine et al. , 
1984b). The yield obtained by Katsunuma et al.,(1980) and 
Siddiqui et al. ,(1980) was quite low i.e. about 40 mg of 
inhibitor per litre of serum. Abdullah et al. , (1983) 
modified their previous procedure (Siddiqui et al., 1980) 
and got a yield of 80 mg of inhibitor per litre of serum 
which was found to be comparable to that obtained by Travis 
et al., (1978b). However, the maximum yield of 250-300 mg 
-16-
of inhibitor per litre of serum was obtained by Laine et 
al., (1984b). 
Chymotrypsin inhibitor was also isolated from 
other sources such as snake venom(Liu et al.,1983; Ritonja 
et al., 1983a ; 1983b )j marine turtle egg white (Guha and 
Sinha, 1984), ascaris (Babin et al. , 1984) and silkworm 
hemolymph (Eguchi and Shomoto, 1984) but none of them was 
found to be similar to that of human alpha,-antichymotry-
psin. However, human plasma alpha-,-antichymotrypsin shows 
immunological identity with inhibitor isolated from the 
plasma of Pan troglodytes (Chimpanzee) and Erythrocebus 
pattas (an old world monkey) but not with nine non-primate 
eutheria plasmas (Bauer, 1973). In porcine serum, no 
counterpart of human alpha-, -antichymotrypsin was found 
although proteinase inhibitors similar to other human 
proteinase inhibitors were detected (Westrom, 1979a; 1979b) 
However, from an invertebrate source i.e. silkworm larval 
hemolymph chymotrypsin inhibitor was isolated which 
resembles with human alpha-,-antichymotrypsin in size, mode 
of association with proteinases and active site location 
(Sasaki,1985). 
-17-
2. Properties: 
i) Molecular Properties 
In general alpha,-antichymotrypsin from human 
blood has been characterized for its molecular weight. It 
has been determined usually by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (Travis et al., 1978b; 
Siddiqui et al., 1980; Laine and Hayem, 1981; Laine et al., 
1984b) and on two occasions by sedimentation equilibrium 
(Travis et al., 1978b; Katsunuma et al., 1980). The values 
of molecular weight obtained, under native and denaturing 
conditions, thus far are listed in Table IV. The molecular 
weight of alpha-,-antichymotrypsin determined both by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis and 
sedimentation equilibrium was found to be same i.e. 66 kDa. 
Since the inhibitor contains 26% carbohydrate (Tsuda et 
al. , 1982) the molecular weight of the polypeptide would be 
about 47 kDa (Matsumoto et al. , 1982b). From amino acid 
sequence the molecular weight of the inhibitor was 
calculated as 46 kDa (Chandra et al., 1983). 
As the molecular weight of the inhibitor was 
found to be same with or without 2-mercaptoethanol. It was 
concluded that inhibitor consists of a single polypeptide 
chain (Travis et al., 1978b; Siddiqui et al., 1980; Laine 
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and Hayem, 1981). Under native conditions the gel 
filtration data on Sephadex G-200 column also indicates its 
monomeric nature (Siddiqui et al., 1980). 
The sedimentation coefficient of the inhibitor was 
determined as 3.9 s (Schwick and Haupt, 1984). The partial 
specific volume of the inhibitor, calculated from its amino 
acid and carbohydrate composition, was found to be 0.715 
ml/g (Travis et al.,1978b). The inhibitor preparation 
which was homogeneous with respect to size as indicated by 
SDS-PAGE gave as many as seven protein bands on isoelectric 
focussing with isoelectric points lying in the range of 
4.1-4.45 (Gianazza and Arnaud, 1981). This microhetero-
geneity is not entirely due to unequal sialylation of the 
protein since microheterogeneity persists even after 
neuraminidase treatment. 
The human alpha-,-antichymotrypsin stored for one 
month in 0.05 M Tris, 0.05 M sodium chloride, pH 8.0, at 
4 C retained its inhibitory activity; under frozen 
conditions the inhibitor can be kept without inactivation 
for substantially longer time (Travis et al., 1978b). The 
inhibitor was found to be stable in the pH range of 5.0-8.0_, 
however, its acidification to pH 3.0 abolished its activity 
-20-
(Travis et al. , 1978a). When the concentration of 
inhibitor is increased to more than 3 mg/ml, the inhibitor 
undergoes polymerization and eventually precipitation 
(Travis et al.,1978b). The inhibitor is heat stable upto 
50 C beyond which further heating causes its inactivation 
(Matsumoto et al., 1982b ;Tsuda et al., 1986). Specific 
oxidants of methionine residue like N-bromosuccinimide or 
N-chlorosuccinimide (Travis et al., 1978b) and myeloper-
oxide in the presence of H„Op and chloride ion (Matheson 
et al., 1979) fail to inactivate alpha-,-antichymotrypsin. 
However, on exposure of inhibitor to ozone, 50% of its 
inhibitory activity was lost and amino acid analysis of 
ozone exposed inhibitor showed the destruction of Trp, Met, 
Tyr and His (Smith et al., 1987). 
ii) Optical properties 
Human alpha-,-antichymotrypsin has been found to 
absorb at 280 nm and using 1% solution of the inhibitor its 
2 -1 
extinction coefficient was determined as 6.2 cm g (Travis 
et al., 1978b). Laine et al. , (1982b) have studied the 
circular dichroism spectra of human alpha-, -antichymotrypsin 
in 10 mM sodium phosphate buffer, pH 7.5, containing 0.3 M 
sodium chloride and 0.2% sodium azide in the wavelength 
-21-
region of 200-350 nm. The characteristic features of the 
near UV CD-spectra of the inhibitor were peak at 267 nm, 
shoulders at 262 and 272 nm, a negative band at 284 nm, a 
positive band at 298 nm and the isobestic points at 277 and 
292 nm. The fine structure between 260-275 nm were 
assigned to phenylalanine residues (Strickland, 1974). The 
trough at 284 nm was due to tyrosine and tryptophan 
residues whereas the positive band at 298 nm was probably 
due to tryptophan residues. The fine structure of the 
CD-spectra of alpha,-antichymotrypsin in the wavelength 
region of 260-350 nm were significantly altered upon its 
interaction with specific enzymes like cathepsin G and 
chymotrypsin. However, the far UV CD-spectra of the 
inhibitor showing minima at 222 nm and a shoulder at 214 nm 
remain uninfluenced by its interaction with the proteolytic 
enzymes. It should be pointed out that for a typical 
helical polypeptide the characteristic feature of the 
CD-spectra include minima at 208 and 222 nm (Greenfield and 
Fasman, 1969). In the CD spectra of the inhibitor the 
trough at 208 nm is replaced by a shoulder at 214 nm which 
might be due to the presence of slightly deformed 
alpha-helix. 
-22-
iii) Chemical properties 
a) Amino acid and carbohydrate composition 
Human alpha-,-antichymotrypsin contains 408 amino 
acid residues in a single chain with covalently bound 
carbohydrate moieties (Chandra et al. , 1983). The amino 
acid composition of the inhibitor has been determined by 
chemical methods (Heimburger et al., 1971; Travis et al., 
1978b; Laine and Hayem, 1981) and has also been deduced by 
base sequence of cDNA for alpha-,-antichymotrypsin (Chandra 
et al., 1983). The results are summarized in Table V. It 
can be seen that number of basic amino acid residues i.e. 
Lys, Arg and His are 52 and acidic amino acid residues are 
also 52 but there are 14 sialic acid residues in the 
inhibitor. Thus this composition is consistent with the 
acidic behaviour of the inhibitor. The total number of 
hydrophobic amino acid residues are 179 which form about 
44% of the total amino acids. The number of Trp, Tyr and 
Phe residues are respectively 4, 10 and 24. For every 24 
amino acid residues, there is one proline residue in the 
molecule. The carbohydrate moieties present in the 
inhibitor are 36-41 neutral hexose residues, 25-35 N-acetyl 
hexosamine and 11-16 sialic acid residues per mole of 
inhibitor. Heimburger et al., (1971) reported that neutral 
-23-
TABLE V 
AMINO ACID AND CARBOHYDRATE, COMPOSITION OF HUMAN ALPHA -
ANTICHYMOTRYPSIN 
Amino acid/carbohydrate residues/ mole 
residues 
Lysine 
Histidine 
Arginine 
Aspartic acid/Asparagine 
Glutamic acid/Glutamine 
Threonine 
Serine 
Proline 
Glycine 
Alanine 
J$--cystine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Tryptophan 
Neutral sugar 
N-Acetyl hexosamine 
Sialic acid 
A 
28 
9 
15 
47 
54 
32 
31 
15 
16 
31 
--
25 
12 
20 
54 
10 
26 
3 
41 
25 
14 
B 
27 
9 
15 
49 
50 
31 
32 
15 
18 
34 
2 
27 
11 
23 
56 
9 
24 
4 
38-40 
30-35 
11-14 
C 
28 
9 
18 
48 
50 
30 
34 
18 
20 
33 
--
21 
10 
15 
53 
11 
21 
NO 
35 
25 
10 
D 
27 
8 
17 
26/17 
26/18 
27 
37 
16 
15 
30 
2 
24 
12 
21 
48 
9 
24 
4 
ND 
ND 
ND 
References: A) Heimburger et al., (1971); 
B) Travis et al., (1978b); 
C) Calculated according to the data of Laine and 
Hayem (1981); 
D) Chandra et al., (1983). 
ND - not determined 
-24-
hexose moieties present are galctose and mannose. Fucose 
(3%) is also present and- no N-acetyl galactosamine was 
found in alpha,-antichymotrypsin. 
b) Amino acid sequence 
The amino acid sequence of the human alpha-j^-
antichymotrypsin as deduced from cDNA (Chandra et al.,1983) 
is given in Fig. 1. Being a secretory protein, the 
inhibitor contains a signal peptide of 22-25 amino acid 
residues in which majority of the amino acid residues are 
hydrophobic in nature. The N-terminal amino acid residue 
is asparagine which was also determined by chemical method 
(Laine et al., 1984b). This is in contrast to the earlier 
report of arginine as the N-terminal residue (Travis et 
al., 1978b; Laine and Hayem, 1981). The C-terminal amino 
acid residue is glutamine which differs from earlier 
finding where glycine was found to be C-terminal residue of 
the inhibitor (Travis et al., 1978b). 
The distribution of acidic and basic amino acid 
residues in human alpha-,-antichymotrypsin, as derived from 
amino acid sequence given in Fig.l, are graphically shown 
in Fig. 2. It can be seen that majority of the side chain 
carboxyl groups are found in the regions in sequence namely 
-25-
Fig.l. Amino acid sequence of alpha,-antichymotrypsin 
as obtained by cDNA studies ( Chandra et al., 
1983). 
AMINO ACID SEQUENCE OF HUMAN 
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Asp 5 - Asp 30, Glu 120 - Asp 147 and Asp 255 - Glu 285. 
There are three clusters of positively charged groups (i.e. 
basic amino acid residues) located between His 65 - Arg 98, 
Lys 152 - Lys 172, and Lys 272 - Arg 295. Out of the 30 
amino acid residues in the N-terminal portion 7 are acidic 
amino acid residues and only two are basic. Accordingly 
out of 28 amino acid residues at the C-terminal end 4 are 
basic amino acid residues and one is acidic. Thus N and C 
terminal portions of the inhibitor are predominantly acidic 
and basic in nature. The distribution of hydrophobic and 
hydrophilic amino acid residues appears to be random as can 
be seen in Fig.3. 
Reactive site sequence' 
The lone reactive site of the inhibitor for the 
corresponding proteolytic enzymes lies near the carboxyl 
end. The reactive site amino acid residues have been 
identified as Leu — Ser (Morii and Travis, 1983) and 
located at positions 358 and 359 of the inhibitor (Chandra 
et al., 1983). Other functionally relevant residues of the 
inhibitor are given in Table VI which also contains the 
active site residues of other serine proteinase inhibitors. 
From the table it is clear that inhibitory specificity of a 
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serine proteinase inhibitor is primarily defined by a 
single amino acid residue at the reactive centre i.e. P-, 
residue. For example, methionine ( or valine) for elastase, 
lysine for trypsin, leucine for chymotrypsin and arginine 
for thrombin. P'-, position appears to be invariant in five 
of the seven inhibitors listed in Table VI. Semisynthetic 
substitution studies showed that serine in this position is 
better than any other amino acid residue whose substitution 
has been attempted (Laskowaski and Kato, 1980). While 
alanine and threonine can substitute for serine at P'-, 
position as in mouse contrapsin (Hill et al. , 1984) and CI-
inhibitor, the replacement of serine by proline renders the 
inhibitor inactive towards the proteases (Laskowaski and 
Kato, 1980). 
Mutation at P, position alters the specificity of 
the inhibitor towards proteolytic enzyme e.g. mutation of 
358 Met — > Arg in alpha-,-antitrypsin Pitsburgh mutant 
results in the change of specificity of the inhibitor from 
trypsin to thrombin (Owen et al., 1983). The functional 
role played by other residues i.e. P„, P.,, P., P'-,, P'o/ 
P'. etc. are yet to be studied. However, in case of o^,-AT 
Christchurch, 363 Glu — > Lys mutation at P' position does 
-31-
not effect its inhibitory activity indicating that P'c 
residue is not critically involved in determining the 
specificity or mechanism of action of inhibitor (Brennan 
and Carrell, 1986). With the exception of mouse 
contrapsin, in all serine proteinase inhibitors the residue 
at position P„ is neutral, consistent with its burial in 
the enzyme inhibitor interface. However, at positions P^, 
Pp,?'-, and P'. proline helps in maintaining the reactive 
site geometry even though this can be achieved without 
proline (Laskowaski and Kato, 1980). Removal of P'-, amino 
acid residue or insertion of an additional residue between 
p., and P'-, in soyabean trypsin inhibitor abolish its 
inhibitory activity. According to Kowalski and Laskowaski 
(1976a; 1976b) this may be due to the fact that either 
reformation of P, - P' peptide bond is not possible or the 
required site geometry is destroyed. 
3. Limited proteolysis: 
Alpha,-antichymotrypsin and alpha,-proteinase 
inhibitor on incubation with catalytic amount of snake 
venom or bacterial metalloproteinases are converted into 
inactive modified form while other serine proteinase 
inhibitors like Cl-Inh, antithrombin III and alpha^-
-32-
antiplasmin first converted into active modified form which 
on further cleavage resulted in the formation of inactive 
modified inhibitor (Kress, 1986), Amino acid sequence 
analysis showed that noninactivating cleavage occurred in 
the N-terminal region of the inhibitor while in all cases 
inactivation resulted from the cleavage of a single bond 
near, but not at, the active site in the C-terminal region 
of the inhibitor. Thus there are two regions in the 
inhibitors which are susceptible to limited proteolysis, 
one near the N-terminal end and other in the C-terminal end 
at exposed reactive site of the inhibitor. 
4. Sequence homology: 
Human plasma serine proteinase inhibitors formed 
a family called "Serpins". These serpins share about 30% 
of common sequence which rises to 70% when only hydrophobic 
amino acid residues are considered (Carrell and Travis, 
1985). Since the hydrophobic amino acid residues form 
interior of the native protein conformation, their 
conservation during evolution is quite expected. 
Comparison of amino acid sequences of three 
serine proteinase inhibitors i.e. alpha-,-antichymotrypsin, 
alpha-]-antitrypsin and antithrombin III revealed 33-42% 
-33-
homology (Chandra et al., 1983). Dot matrix analysis 
indicated higher level of sequence homology throughout the 
amino acid sequences of alpha-,-antichymotrypsin and alpha,-
antitrypsin. However, as compared to C-terminal half, the 
sequence at N-terminal half of two proteinase inhibitors 
exhibited significantly higher level of homology. The 
comparison of alpha,-antichymotrypsin with antithrombin III 
showed a much more scattered pattern on dot matrix analysis 
indicating that the two sequences are much less conserved. 
The amino acid sequences surrounding the active sites of 
these three proteinase inhibitors were also compared (See 
Fig. 4) and it was found that homology at the active sites 
is much less extensive than 5-10 residues away from the 
active sites. 
The gene for alpha,-antichymotrypsin is located 
in the q31 - q32.3 region of human chromosome 14 (Rabin et 
al., 1986) and is approximately 12 kb long containing five 
exons and four introns as shown in Fig.5 (Bao et al., 1987) , 
All five exon containing regions of the gene are sequenced 
and the sequences at each exon-intron boundary is shown in 
Fig.6. The gene for alpha,-antitrypsin is also located at 
the q31-q32 region of human chromosome 14 (Schroeder et 
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E E 
B B 
Hin 
d l l l 
i+ 
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I II 
19.0 
Kb 
Haell 
i± 
B 
III IV V 
Hin 
dlll 
F i g - 5 . Restriction map of Hin d III. EcoRI(E), Bam HI 
(B ) and Hae- II s i tes in human chromosomal alphoi-
antlchymotrypsln gene. E xons are denoted by solid 
boxes and marked I-V ( Bao e t a l . , 1987). 
- 35 -
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Exon I Intron A Exon II 
TCC CTG AGG GAG geta ate dtca cag TTG AGA ATG GAG. 
Met Glu 
-25 -24 
Exon II Intron B Exon III 
TTC TTT AAA G gtg agt ctt cag CC AAA TGG GAG 
Phe Phe Lys Ala Lys Trp Glu, 
187 188 189 190 191 192 193 
Exon i n Intron C Exon IV 
CTG GAG TTC AG gtg att ttc tag A GAG ATA GGT 
Leu Glu Phe Arg Glu lie Gly 
278 279 280 281 282 283 284 
Exon IV Intron D Exon V 
GCA GTC TCC CAG gtg agt gac gag GTG GTC CAT AAG, 
Ala Val Ser Gin Val Val His Lys 
328 329 330 331 332 333 334 335 
Fig. 6. Exon - intron junction sequences of alpha-,-
antichymotrypsin gene ( Bao et al., 1987). 
Exon sequences are in capital letters and 
intron sequences in small letters. The 
numbers shown denote the positions of 
corresponding amino acids in the gene. 
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et al., 1985; Rabin et al., 1986) and in both the genes the 
number and positions of introns and type of exon intron 
junctions are similar, if not identical (Bao et al. , 1987). 
The similar organization of alpha-,-antichymotrypsin and 
alpha,-antitrypsin gene is consistent with the high degree 
of homology in their amino acid sequences. Despite the 
fact that there is sequence homology in alpha,-antichymo-
trypsin and antithrombin III the number and positions of 
introns in two genes are very much different (Bao et al., 
1987) . 
5. Interaction of alpha,-antichymotrypsin with serine 
proteinases: 
Human alpha,-antichymotrypsin is specific for 
chymotrypsin, both bovine and human (Travis et al., 1978a; 
1978b; Laine et al., 1984a), leukocyte cathepsin G (Laine 
et al., 1982a), cathepsin G from sputum (Laine et al., 
1984b), dog and human mast cell chymases (Travis et al. , 
1978a; Reilly et al ., 1982), human pancreatic elastase 
2 ( Laine et al., 1985; Davril et al. , 1987) and porcine 
pancreatic elastase (Laine et al., 1985). The values of 
the rate constant of interaction of inhibitor with some 
serine proteinases is listed in Table VII. Evidently human 
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TABLE VII 
ASSOCIATION RATE CONSTANTS FOR THE INTERACTION OF 
ALPHA - ANTICHYMOTRYPSIN WITH DIFFERENT ENZYMES 
Enzymes Association rate References 
constant 
7 
1. Human cathepsin G S.lj^O.VxlO Beatty et al. , 
(1980) 
4 
2. Human chymotrypsin 1.0 + 0.1 x 10 Beatty et al., 
(1980) 
4 
3. Bovine chymotrypsin 6.0 +_ 1.0 x 10 Beatty et al. , 
(1980) 
5 
4. Human pancreatic 8.9 j^  1.3 x 10 Laine et al., 
elastase 2 (1985);Davril 
et al.,(1987) 
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alpha-,-antichymotrypsin associates with human cathepsin G 
at the fastest rate followed by human pancreatic elastase 
2. Bovine chymotrypsin was indistinguishable from human 
chymotrypsin The fact that with human cathepsin G the 
rate of complex formation is fastest suggests that the 
inhibitor preferentially interacts with cathepsin G ( Travis 
et al. , 1978a). It was also found to inhibit porcine 
pancreatic elastase but the inhibition is so slow that it 
has no physiological significance (Laine et al., 1985). 
Neither human trypsin nor neutrophil elastase was found to 
be inhibited by alpha,-antichymotrypsin (Travis et al., 
1978a). 
It is also possible to calculate half time of 
inhibition, t, , from the kinetic data of association of 
inhibitor with enzyme (Beith, 1980). The values for tj for 
cathepsin G and chymotrypsin was calculated as 5 
milliseconds and 27 seconds respectively (Travis and 
Salvesen, 1983). 
Mechanism of interaction of inhibitor with enzyme 
The proteinase inhibitor interacts with the 
corresponding proteinases through the binding of active 
site of proteinase to the corresponding substrate like 
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region on the inhibitor i.e. reactive site of inhibitor 
(Ozawa and Laskowaski,1960). The reactive site of the 
inhibitor is fairly rigid^ consequently little or no 
conformational changes occur when inhibitor combines with 
enzyme (Laskowaski and Kato,1980). The peptide bond 
joining P, and P'-, is hydrolyzed during the complex 
formation (Travis and Salvesen, 1983). The value of 
k ./K for the hydrolysis of this peptide bond at neutral 
pH is very high, lO'^-lO^ M""^ S"""" (Estell et al., 1980) as 
3 
compared to the value for normal substrate i.e. about 10 
M~ s~ (Laskowaski and Kato, 1980 ). However the 
individual values of k , and K for inhibitor are several 
cat m 
orders of magnitudes lower than those for normal substrate 
(Laskowaski and Kato, 1980). Thus the hydrolysis of the 
peptide bond (P-, - P'T) is very slow and does not proceed 
to completion (Laskowaski and Kato, 1980). The rate of 
complex formation of enzyme with modified inhibitor i.e. 
inhibitor with peptide bond cleaved is much lower than that 
from virgin inhibitor and in few cases this difference is 
so large that it led to the assumption that the modified 
inhibitor was inactive, however, on longer incubation it 
was found to be an error (Laskowaski and Kato,1980). 
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According to Travis and Salvesen (1983) the enzyme and 
inhibitor interaction takes place according to following 
scheme:-
E + I • v: "* EI ^ = ^ C < '^  EI* V. ^ E + I* (2) 
Where E and I refer to proteinase and inhibitor, 
respectively, I* is the modified inhibitor and C is the 
stable complex. In the stable complex C the scissile 
peptide bond (P, ~ ^' i ) °f the inhibitor is not cleaved. 
But the carbonyl carbon of reactive site peptide bond 
(P-, residue) is distorted about halfway towards tetrahedl^al 
state from its fully trigonal state and it was believed 
that this distortion is caused by 0 of catalytic Ser of 
enzyme (Laskowaski and Kato, 1980). However, this view was 
questioned as it was found that anhydrotrypsin, where the 
195 195 
catalytic Ser is dehydrated to dehydrolanyl , can form 
stable complexes with inhibitor of comparable strength 
(Ako et al., 1974), having the same geometry (Huber et al., 
1975) and almost with same tetrahedral dstortion as in a 
complex with trypsin (Huber et al. , 1974). Accordingly 
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Kraut (1977) proposed that this partial tetrahedral 
distortion is the result of attraction between the carbonyl 
oxygen of the inhibitor and the oxyanion hole of the enzyme, 
193 195 
the NH' s of glycine and serine . Thus the carbonyl 
y 
carbon is now ready for the attack by oxygen 0 of 
195 
serine , but in the stable complex the attack has not yet 
taken place (Laskowaski and Kato, 1980). This bond in 
addition to other interactions including hydrogen bonds, 
Van der Waal's interactions, hydrogen bonds and salt bridges 
in the close contact area between the reactive site of 
inhibitor and enzyme, all contribute to the characteristic 
stability of the complex (Laskowaski and Kato,1980). 
Alpha,-antichymotrypsin and other serine 
proteinase inhibitors obey atleast a part of the standard 
mechanism i.e. they rapidly from complexes with their target 
enzymes via reactive site region. However, the modified 
inhibitor formed by cleavage of reactive site peptide bond 
is inactive and cannot recombine with proteinases e.g. 
cathepsin G and chymotrypsin on incubation with alpha-,-
antichymotrypsin produce an inactive form of inhibitor 
(Laine et al. , 1982a). The rate of breakdown of complexes 
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to form inactive inhibitor is not reported in case of 
alpha,-antichymotrypsin - proteinase complex but for various 
proteinase - alpha,-proteinase inhibitor complex, it was 
found to be quite slow i.e. 6 x 10 sec - 3 x 10 sec 
(Aubry and Beith, 1972; Beatty et al. , 1982). The 
following kinetic scheme was summarized for interaction of 
alpha-j^-antichymotrypsin with enzyme (chymotrypsin) by Laine 
et al,, (1984a) 
E + I 3 EI -^  EI* + peptide (3) 
where E is enzyme, I the inhibitor^ EI an enzyme substrate 
type complex, EI* the covalent complex and I* the modofied 
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inhibitor. The k_-, path was reported in case of 
alpha,-proteinase inhibitor by Beatty et al., (1982). 
However, in case of alpha-,-antichymotrypsin this path has 
not yet been established. It was also found that the 
complex (alpha,-proteinase inhibitor - chymotrypsin) does 
not dissociate if the complex had been previously treated 
with diisopropyl fluorophosphate (Lobermann et al. , 1982). 
Therefore, it is still unclear that whether the breakdown 
of the complex is due to the proteolytic activity of the 
released enzyme or there is inherent instability of the 
complex. The inactive modified alpha,-antichymotrypsin can 
react with antibodies raised against native inhibitor 
indicating that it must have retained the antigenic 
determinants of native inhibitor (Laine et al., 1984a). 
Alpha2-macroglobulin plays an important secondary 
role in backing up the primary function of the inhibitor. 
In vitro, the experiments showed that all the proteinases 
bound to serine proteinase inhibitor dissociate, although 
slowly, and transferred to alpha2-macroglobulin. The 
complex formed with alpha_-macroglobulin is irreversible 
and does not dissociate (Laskowaski and Kato,1980). In 
vivo, this effect is greatly exaggerated since 
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alpha„-macroglobulin - proteinase complexes are cleared 
very rapidly by reticuloendothelial cells (Debanne et al. , 
1975; Ohlsson and Laurell, 1976), the half life is about 10 
minutes in man ( Balldin et al. , 1978). Thus essentially 
all the proteinases are cleared by OC^M - pathway and other 
serine proteinase inhibitors are only transiently involved 
in transferring the proteinases to be cleared. But in 
mouse it was found that clearance of O^p-M-complex is 
separate from that of other inhibitor complexes (Fretz and 
Gan, 1980; Fuchs et al. , 1982). Therefore, the 
physiological significance of this mechanism remains 
equivocal. 
A review of the existing literature shows that 
except human alpha,-antichymotrypsin, inhibitor of 
identical specificity from other mammalian blood have not 
been investigated in essential detail thus far. In fact no 
such inhibitor could be detected in porcine serum (Westrom, 
1979a; 1979b). Strikingly chymotrypsin inhibitor from some 
invertebrates have been found to vary considerably in 
molecular properties (Liu et al. , 1983; Ritonja et al. , 
1983a; 1983b; Guha and Sinha, 1984; Babin et al., 1984). 
In this thesis we report the isolation and characterization 
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of chymotrypsin inhibitor from goat plasma which has not 
been studied thus far. The properties of plasma and serum 
goat chymotrypsin inhibitors were found to be 
indistinguishable. Some molecular and functional properties 
of goat chymotrypsin inhibitor are being presented here for 
the first time. 
EXPERIMENTAL 
A. Mater ia ls : 
1. Proteins 
Bovine serum albumin (lot no. lOOF - 033), 
ovalbumin (lot No. 105C - 8022), pepsin (lot No. 
60F - 8056), chymotrypsinogen - A (lot no. 40F -
8050), cytochrome c (lot no.09C - 088), trypsin 
(lot no. 103F - 8075) and bovine pancreatic 
chymotrypsin (lot no. C - 4129) were purchased from 
Sigma Chemical Company,St. Louis, Mo., USA. Casein 
was isolated from skimmed milk by acid precipita -
tion followed by washing with alcohol and ether as 
described earlier (Maheshwari , 1979). 
2, Buffer components 
The monobasic and dibasic salts of phosphoric 
acid and sodium chloride for the preparation of 
sodium phosphate buffer were from Sarabhai M. 
Chemicals, Baroda, India. Potassium hydrogen 
phthalate and sodium tetraborate which were used 
for the preparation of standard buffers, were 
obtained from BDH, Bombay, India. For the prepa-
ration of Tris-glycine buffer, Tris (lot no.T-1378) 
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was purchased from Sigma Chemical Company, St.Louis, 
Mo., USA and glycine from BDH, Bombay, India. 
3. Column chromatographic media 
DEAE - cellulose (lot no. 43C - 1140), Dowex 
1x4 - 100 { lot no. 39C - 0273) and Dowex 50x4 -
100 ( lot no. 43c - 1140), were purchased from 
Sigma Chemical Company, St. Louis, Mo., USA. 
Sephadex G-200 was purchased from Pharmacia Fine 
Chemicals, Uppsala, Sweden. 
4 . Reagents used for gel electrophoresis 
Reagents used in electrophoresis with their 
sources in parenthesis were: acrylamide (E.Merck, 
Dramstadt, Germany), N,N' - methylene-bis-acryla-
mide (Reanal, Budapest, Hungary),N, N ,N ' ,N ' 
tetramethylethylenediamine (Ferak, Berlin, West 
Germany), ammonium persulphate ( E. Merck, 
Dramstadt, Germany), riboflavin and dichlorodi-
methyl silane ( BDH, Poole, England), sodium 
dodecyl sulphate ( BDH, Bombay, India), 2-mercapto-
ethanol (BDH, Poole, England) , coomassie 
brilliant blue R ( lot no. B - 0630, Sigma Chemical 
Company, St. Louis, Mo., USA), glycerol, sucrose, 
isopropanol and chloroform (BDH, Bombay, India). 
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5. Miscellaneous reagents 
Other reagents used were: N-acetylneuraminic 
acid (lot no. A - 2501) ,pCMB ( lot no. T-7254) from 
Sigma Chemical Company, St. Louis, Mo., USA, agar 
(S.D. Fine Chemicals, Bombay, India), phenol, 
sodium metaperiodate, sodium arsenite, 
thiobarbituric acid, sodium sulphate and cyclohexa-
none (BDH, Bombay, India). The rest of the 
chemicals used were of analytical grade. 
All glass distilled water was used throughout 
the experiments. 
B. Methods: 
1. Preparation of solutions 
i) Preparation of Folin-phenol reagent 
The Folin - phenol reagent was prepared by the 
method of Folin and Ciocalteu (1927). Hundred 
grams of sodium tungstate, 25 grams of sodium 
molybdate, 700 ml of distilled water, 48.2 ml of 
orthophosphoric acid and 100 ml of concentrated 
hydrochloric acid were mixed together and the 
contents were refluxed gently for 10 hours in a 
round bottom flask wrapped with black carbon paper. 
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After cooling, 128.88 grams of lithium sulphate, 
50 ml of distilled water and few drops of bromine 
were added. The mixture was boiled for 15 minutes 
to remove excess bromine. The solution was cooled, 
filtered and diluted to one litre. The reagent was 
stored in a brown coloured bottle and it was 
diluted five times with distilled water before use. 
ii) Preparation of copper reagent 
The copper reagent was prepared by mixing 4% 
sodium carbonate, 4% sodium potassium tartarate and 
2% copper sulphate in a ratio of 100 : 1 : 1. 
iii) Preparation of Schiff reagent 
The Schiff reagent was prepared by dissolving 
1.25 grams of basic fuchsin in 250 ml of distilled 
water, then adding 5 grams of sodium metabisulphite 
and 50 ml IN HCl. The solution was stirred for 6 
hours at room temperature and then decolourised 
with activated charcoal, 
iv) Preparation of pHMB solution 
p-chloromercuribenzoate was dissolved in 
alkaline aqueous solution in order to convert it 
into pHMB. This solution was prepared in 10 mM 
sodium phosphate buffer, pH 7.0, and its 
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concentration was measured spectrophotometrically 
by measuring optical density at 232 nm using molar 
extinction coefficient of 16,900 (Scoffone and 
Fontana ,1970). 
v) Preparation of deionized protein solution 
The protein solution was dialyzed extensively 
against deionized water which was previously 
prepared by passing glass distilled water through a 
mixed ion exchange resin column prepared from Dowex 
1x4 - 100 and Dowex 50x4 - 100. The protein 
solution was then passed repeatedly through the 
Dintzis column as reported earlier ( Ahmad and 
Salahuddin, 1974). The concentration of isoionic 
protein solution was determined by the method of 
Lowry et al. , (1951) to the first approximation 
and its pH was immediately measured on EC digital 
pH meter. 
pH measurement 
pH of the solution was measured either on EC 
digital pH meter (serial 022 pH 5651) or on Elico 
digital pH meter (model LI - 120). Before 
measurement, the pH meter was calibrated either 
with 0.05 M potassium hydrogen phthalate buffer, 
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pH 4.0, in an acidic pH range or with O.Ol M sodium 
tetraborate buffer, pH 9.2, in the basic pH range. 
Optical measurement 
Absorbance of the solution in the visible 
range was measured on a Photochem Colorimeter,, 
model C - 110. In the UV region, light absorption 
measurements were performed on Cecil UV - Spectro-
photometer, model CE 202 and on Cecil UV and Double 
Beam Spectrophotometer, model CE 594. Fluorescence 
measurements were carried out on Shimadzu Spectro-
fluorometer, model RF - 540, in conjunction with 
fitted Shimadzu Data Recorder, DR - 3, using quartz 
cell of 1 cm path length. 
Determination of protein concentration 
Protein concentration was determined routinely 
by the method of Lowry et al., (1951) using 
crystalline bovine serum albumin as standard and 
occasionally at 280 nm using the specific 
2 -1 
extinction coefficient of 6.23 cm g ( a s 
determined for chymotrypsin inhibitor) and 20.5 
2 -1 
cm g for chymotrypsin ( Wilcox, 1970). 
Chromatography 
a) Ion exchange chromatography 
Ion exchange chromatography was carried out on 
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DEAE - cellulose column ( 2.4 x 6.0 cm). In order 
to regenerate DEAE resin, it was suspended in 0.1 N 
NaOH and washed repeatedly with distilled water 
till the pH was close to neutral. The resin was 
then treated with 0.1 N HCl and again washed 
repeatedly with distilled water. After packing the 
column, three times bed volume of 10 mM sodium 
phosphate buffer, pH 7.5, containing 50 mM sodium 
chloride and 0.02% sodium azide was passed to 
equilibrate it. The protein was applied on the 
column with a flow rate of 10 ml/hr and the bound 
protein was eluted using discontinuous gradient of 
sodium chloride at a flow rate of 40 ml/hr. 
b) Gel chromatography 
Hydrodynamic properties of chymotrypsin 
inhibitor were studied by gel filtration on a 
Sephadex G - 200 column (2.4 x 78 cm). The column 
was packed by the method of Ansari and Salahuddin 
(1973). About 10 grams of gel was allowed to swell 
in distilled water for about 6 hours in an oven. 
The fine particles were then removed by 
decantation. This process was repeated several 
times until the gel was free from fine particles. 
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A glass column (2.4 x 90 cm) was taken and washed 
with detergent, chromic acid and then finally with 
distilled water. The column was then mounted in a 
vertical position with help of clamps. Before 
packing the column, its diameter was determined at 
different positions along the height of the column. 
At three places, 2 cm length of graph paper was 
pasted and column was filled with distilled water. 
Volume of water corresponding to 2 cm length was 
collected in three preweighed weighing bottles. 
The volume of water corresponding to 2 cm length 
was then determined by dividing the weight of water 
(W) by its density (d) at room temperature 
V = 7T r^l = W/d (4) 
W or r = ' 
d n 1 (5) 
where r is the radius of the column. From three 
independent measurements, the weight of the water 
was found to be 26.9 grams at temperature 17 C at 
which density of water is 0.99766 (Merck Index, 
1968). The radius of the column computed from 
equation (5) turns out to be 1.2 cm. Corresponding 
to bed height of the column as 78 cm, the total 
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volume of the column was calculated as 353 ml. 
After determination of radius of the column a 
small amount of glass wool, previously boiled in 
water, was placed at the bottom of the column with 
the help of a glass rod. Few glass beads were 
placed on the surface of glass wool. Half of the 
glass column was then filled with the operating 
buffer(10 mM sodium phosphate buffer, pH 7.5, 
containing 150 mM sodium chloride and 0.02% sodium 
azide) keeping the outlet closed. An extension 
glass column ( 1.6 x 68 cm ) was fitted on the top 
of the column and the gel slurry was then poured 
slowly into the column through the extension with 
the help of a glass rod. As the gel settled down 
the flow rate was increased gradually from 5 ml/hr 
to 30 ml/hr. The column was then equilibrated with 
operating , buffer by passing the volume of the 
buffer equal to three times the bed volume of the 
column. The packing of the column was checked by 
passing 0.5% solution of Blue Dextran; the elution 
pattern shows uniform packing. 
The operating buffer on the top of the column 
was first drained off and 2 ml of the sample 
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containing 10 mg of protein was applied on the 
column with the help of an applicator. The stop 
cock of the column was then opened slowly. As soon 
as the solution percolated down and no upper liquid 
layer was visible on the surface, 2 ml of buffer 
was added from the side of the column and the flow 
rate was adjusted as 20 ml/hr. The column was then 
connected to a reservoir containing operating 
buffer. The fractions of appropriate size (2-5 ml) 
were collected and monitored by the method of Lowry 
et al., (1951) . 
Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis of chymo-
trypsin inhibitor was performed in Tris glycine 
buffer, pH 8.2, ( I = 0.02) according to the method 
of Davis (1964). The gel tubes were washed with 
detergent, chromic acid and then with distilled 
water. After drying, the tubes were siliconized 
with 5% dichlorodimethyl silane in chloroform. Two 
ml of small pore gel solution containing 7% 
acrylamide, 0.18% N,N' - methylene-bis-acrylamide, 
0.03% N,N,N',N' - tetramethylethylenediamine 
(TEMED) and 0.07% ammonium persulphate was poured 
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into each tube . After 30 minutes of polymerization 
0.5 ml of large pore gel solution was added to 
each tube. The later contained 2.5% acrylamide, 
0.62% N,N' - methylene-bis-acrylamide, 0.06% TEMED, 
0.001% riboflavin and 2 0% sucrose. The gels were 
kept for 30 minutes for photopolymerization. The 
protein sample was prepared by adding two drops of 
glycerol in 1 ml protein solution having a 
concentration of 1 mg/ml. About 100 ;ug of protein 
was applied and electrophoresed for 3 hrs with a 
current of 2 - 5 mA per tube. The gels were stained 
with a solutiion of 1% amidoschwa.rz in 7% acetic acid 
and destained mechanically with 7% acetic acid. 
7. Chemical analysis 
(a) Estimation of sulfhydryl groups 
The sulfhydryl content of the chymotrypsin 
inhibitor was determined by the method of Neuman et 
al.,(1964) using pCMB in 10 mM sodium phosphate 
buffer, pH 7.0. Chymotrypsin inhibitor (9.4 nM) was 
incubated with increasing concentration of 
p-hydroxymercuribenzoate ( 1.88-28.2 nM) and 
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increase in absorbance at 250 nm was determined. 
b) Determination of carbohydrate content of chymo-
trypsin inhibitor 
i) Neutral hexose 
The hexose content of chymotrypsin inhibitor 
was estimated by the method of Dubois et al. , 
(1956) using galactose as standard. 
First 1 ml of 2% (w/v) phenol solution was 
added to 1 ml carbohydrate or glycoprotein solution 
followed by the addition of 5 ml concentrated 
sulphuric acid. After 15 minutes the colour 
intensity was measured at 490 nm against an 
appropriate blank of bovine serum albumin. A 
calibration curve was obtained with galactose 
(sec Fig. 7) and the curve fits the following 
equation:-
(O.D.)«QQ = 5.73 (mg, galactose) + 0.1 (6) 
ii) Sialic acid 
The sialic acid content of chymotrypsin 
inhibitor was estimated by the method of Warren 
(1959) using N - acetylneuraminic acid as standard. 
The standard curve is shown in Fig. 8 and the 
straight line obtained was found to fit the 
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following equation 
_3 
(O.D.)..Q = 12.54(mg,sialic acid) + 8.1x10 (7) 
The inhibitor ( 0.62 mg in 2 ml) was heated 
with 0.1 N sulphuric acid in a boiling water bath 
for one hour and the released sialic acid was 
estimated. For the determination of sialic acid, 
0.5 ml of this solution was mixed with 0.1 ml of 0.2 
M sodium metaperiodate in 9 M orthophosphoric acid 
and kept at room temperature for 20 minutes. Then 1 
ml of 10% (w/v) sodium arsenite ( in a solution of 
0.5 M sodium sulphate and 0.1 N H^SO,) was added 
with continuous shaking until a yellow colour 
appeared and then disappeared. After this 3 ml of 
0.6% (w/v) thiobarbituric acid ( in a solution of 
0.5 M sodium sulphate) was added and the mixture was 
heated for 15 minutes in a boiling water bath. 
After cooling equal volume of cyclohexanone was 
added and centrifuged at 2000 rpm for 20 minutes. 
The colour intensity of cyclohexanone layer was read 
at 550 nm using an appropriate blank. 
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8. Determination of extinction coefficient 
Isoionic chymotrypsin inhibitor solution was 
taken in preweighed weighing bottles and heated to 
constant weight at 100 C in an oven. After 
measuring the protein concentration by dry weight 
method, absorbance of isoionic protein solution was 
measured at different wave lengths; maximum light 
absorption occurred at 278 nm. The optical 
densities of a series of isoionic inhibitor 
solutions were determined at 278 nm and 280 nm. A 
linear curve was obtained by plotting absorbance at 
278 nm ( and at 280 nm) and protein concentration 
( g/100 ml ). The slopes of the curves were 
m 
computed to be 6.23 and 5.92 at 278 and 280 nm 
respectively. 
9. Determination of molecular weight by sodium dodecyl 
sulphate polyacrylamide slab gel electrophoresis 
The molecular weight of chymotrypsin inhibitor 
was determined by SDS polyacrylamide slab gel 
electrophoresis in 12% polyacrylamide gel. Electro-
phoresis was carried out according to the method of 
Laemmli (1970) in Tris-glycine buffer ( 25 mM Tris 
and 194mM glycine), pH 8.3, containing 0.1% SDS. 
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The glass plates { 192 x 162 x 1.5 mm ) were 
washed first with detergent and then with water. 
After drying, the plates were siliconized with 5% 
dichlorodimethyl silane in chloroform. The glass 
plates were fixed vertically with the help of clamps 
and sealed with 2% agar solution. About 35 ml of 
small pore gel solution containing 12% (w/v) 
acrylamide, 0.6% (w/v) N,N' - methylene-bis-acryla-
mide, 0.05% (w/v) TEMED, 0.0^% ammonium persulphate 
and 0.14% SDS was poured between the plates. After 
polymerization the small pore gel was overlaid with 
a solution of 6% (w/v) acrylamide, 0.13% (w/v) N,N' 
methylene-bis-acrylamide, 0.05% TEMED, 0.12% 
ammonium persulphate and 0.1% SDS. A comb was 
inserted in the gel solution to form wells. After 
20 minutes the comb was removed and the wells were 
layered with distilled water. 
The sample was prepared by heating protein in 
sample buffer (0.06 M Tris - HCl buffer, pH 6.8, 
containing 10% (v/v) glycerol, 2% (w/v) SDS and 
0.05% (w/v) bromophenol blue). The protein 
solutions were heated in a boiling water bath for 20 
minutes. After cooling, 0.02 M 2-mercaptoethanol 
was added, if needed. The protein sample 
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(0.01 - 0.5 ml) containing 25 - 60 jag of protein 
was applied in the well and gently layered with 
electrophoretic buffer. The electrophoresis was 
performed with a current of 2-4 mA per lane for about 
three hours. 
Staining procedure 
The gels were stained for protein and glyco-
protein with coomassie brilliant blue R and Schiff 
reagent respectively, 
i) Staining procedure for protein 
For staining of protein, the dye solution was 
prepared by dissolving 1% coomassie brilliant blue 
R - 250 in a mixture of 50% (v/v) methanol, 10% 
acetic acid and water ( Weber and Osborn, 1969). The 
gel was dipped in staining dye for 1 hr and 
destained mechanically with 10% acetic acid, 
ii) Staining procedure for glycoprotein 
Gels were stained for carbohydrate using PAS 
staining procedure. SDS was removed before staining 
by carrying out following steps 
a) 25% (v/v)isopropyl alcohol and 10% (v/v) acetic 
acid ; overnight 
b) 10% (v/v) isopropyl alcohol and 10% (v/v) 
acetic acid; 6 - 9 hrs. 
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c) 10% (v/v) acetic acid; overnight. 
The fixed gels were treated as follows using at 
least 100 ml of rinsing solution at each stage 
a) 0.5% (w/v) periodic acid; 2 hrs 
b) 0.5% (w/v) sodium arsenite and 50% (v/v) acetic 
acid; 1 hr 
c) 0.1% (w/v) sodium arsenite and 5% (v/v) acetic 
acid; 20 minutes 
d) 10% (v/v) acetic acid; 20 minutes 
e) Schiff reagent; overnight 
f) 0.1% (w/v) sodium metabisulphite in 0.1 N HCl 
The last step was repeated three or four times 
until a pink colour band was appeared. 
10. Measurement of inhibitory activity 
The activity of chymotrypsin inhibitor was 
measured against chymotrypsin and trypsin using 
casein as substrate. 
The proteinase activity was determined by the 
method of Anson (1938) with TLCK treated 
chymotrypsin or trypsin. A standard assay mixture 
contained enzyme ( 0.01%, w/v) and 1% (w/v) casein 
in 10 mM sodium phosphate buffer, pH 7.5, containing 
150 mM sodium chloride. The mixture was incubated 
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at 37°C for 1 hr. The caseinolytic activity was 
measured after stopping reaction with 10% TCA. fn 
control 10% TCA was added to the enzyme solution 
before the addition of casein. The proteinase 
activity was measured both in presence and absence 
of chymotrypsin inhibitor. 
11. Heat treatment of chymotrypsin inhibitor 
Two ml of chymotrypsin inhibitor solutions (1.5 
mg/ml) in 10 mM sodium phosphate buffer, pH 7.5, 
containing 150 m M sodium chloride and 0.02% sodium 
azide were heated in a water bath at 45 C, 50 C, 
55°C and 60°C. After incubation for 15 minutes, the 
solutions were immediately cooled in ice cold water 
and stored at 4°C. The inhibitory activity of 
different preparations at different concentrations 
were measured using casein as substrate. 
12. Isolation and purification of goat chymotrypsin 
inhibitor 
Goat plasma was collected and its protein 
content was determined. Solid ammonium sulphate was 
added to obtain 50% saturation and the pH of the 
solution was adjusted to 4.5 with 4N H-SO.. The 
precipitated prortein was removed by centrifugation 
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and salt concentration of supernatant was raised to 
80%. The precipitated protein was extensively 
dialyzed and then fractionated by ion exchange 
chromatography on DEAE - cellulose column 
equilibrated with 10 mM sodium phosphate buffer, pH 
7.5, containing 50 mM sodium chloride and 0.02% 
sodium azide. The bound protein was eluted using 
discontinuous gradient which is achieved by adding 
different concentrations of sodium chloride ( 50 mM 
- 150 mM ) to 10 mM sodium phosphate buffer, pH 7.5, 
containing 50 mM sodium chloride and 0.02% sodium 
azide. The protein fractions showing antichymo-
tryptic activity were pooled and rechromatographed 
on the same column. 
RESULTS 
1. Isolation of chymotrypsin inhibitor: 
Goat chymotrypsin inhibitor was isolated both 
from serum and plasma by salt fractionation and was further 
purified by ion exchange chromatography on DEAE-cellulose 
column. 
Protein concentration of goat plasma was 
estimated by the method 'of Lowry et al. , (1951) on seven 
samples obtained at different time spreading over a period 
of two years and the results showed the presence of 5.3 -
6.7% protein in the goat plasma; the corresponding value 
in serum was found to be about 5%. Different steps in 
isolation and purification of chymotrypsin inhibitor from 
goat plasma are summarized in Table VIII. Most of the 
plasma proteins including albumin were precipitated 
with 50% ammonium sulphate at pH 4.5 and the 
supernatant containing 1.1 g protein was made 80% with 
respect to ammonium sulphate. The precipitated protein 
(763 mg) as well as the protein in supernatant (176 mg) 
were checked for antichymotryptic activity. The inhibitory 
activity against chymotrypsin was measured as described in 
experimental section and it was located only in the 
-68-
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TABLE VIII 
ISOLATION AND PURIFICATION OF GOAT CHYMOTRYPSIN INHIBITOR 
Isolation Steps Total 
Protein 
% protein 
yield 
% inhibitory 
activity per mg 
of protein 
1. Plasma 53 g 100 
2. 80% ammonium sulphate 
saturation --
i) precipitate 763 mg 1.4 
ii)supernatant 176 mg 0.33 
3. Ion exchange chromato- 80 mg 0.15 
graphy on DEAE -
cellulose column 
(peak III) 
5.0 
16 
100 
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precipitate. The precipitated protein was then 
fractionated by ion exchange chromatography on DEAE 
cellulose column ( 2.4 x 6.0 cm) in 10 mM sodium phosphate 
buffer, pH 7.5, containing 50 mM sodium chloride and 0.02% 
sodium azide. The bound protein was eluted batchwise with 
the buffer containing different concentrations of sodium 
chloride as shown in Fig. 9. The protein eluted with the 
buffer containing 50 mM sodium chloride was devoid of 
antichymotryptic activity and found 39% of the total 
protein applied on the column. About 23 mg protein was 
eluted with buffer containing 100 mM sodium chloride; the 
protein fractions did not show any antichymotryptic 
activity. Likewise peak III and a small peak IV were 
obtained with 150 mM and 200 mM sodium chloride, the 
activity was located in peak III which contained 11.5% of 
the total protein applied on the column. The peak III was 
rechromatographed on the same column and the elution 
profile is shown in Fig. 10. Thus about 80 mg of 
chymotrypsin inhibitor was obtained from one litre of goat 
plasma. Our results are comparable to those obtained by 
Abdullah et al., (1983) who isolated 80 mg of alpha,-anti-
chymotrypsin from one litre human serum by salt fractiona-
tion , ion exchange and affinity chromatography, but 
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r ' 9 - lO. Rechromatography of 80V. ammonium sulphate fraction 
on DEAE-cellulose column. 
The column was equilibrated withlOmM sodium phosphate 
buffer, pH 7.5, containing 50mM sodium chloride and 0.02 7. sodium 
azide. About 30mg of protein collected from the fractions under 
peak 111 of Fig. 1 was applied on the column and the bound protein 
was eluted with lOmM sodium phosphate buffer containing 0 1 M 
&0-15M NaCl at a flow rate of AOml/hr. Each fraction contains 
10 ml eluant. The column was monitored by the method of Lowry 
etal.^(1951). 
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substantially lower than that (250-300 mg) found 
oy Laine et al. , (1984b). However, the yield obtained in 
this study was substantially higher than that (35-40 
mg)found by Siddiqui et al., (1980) and Katsunuma et al. , 
(1980) . 
When purified chymotrypsin inhibitor was 
electrophoresed in Tris glycine buffer (4.95 mM Tris and 
38.4 mM glycine), pH 8.2, in 7% polyacrylamide gel, a 
single band with R value of 0.48 was obtained (see Fig.11) 
The zone broadening may be attributed due to glycoprotein 
nature of inhibitor as it was found to have about 17% 
carbohydrate including 5% sialic acid. When the inhibitor 
was passed on a Sephadex G-200 column equilibrated with 
10 mM sodium phosphate buffer, pH 7.5, containing 150 mM 
sodium chloride and 0.02% sodium azide, it eluted as a 
single symmetrical peak (see Fig. 12). This observation 
taken together with the fact that the inhibitor moved as a 
single band in sodium dodecyl sulphate polyacrylmide gel 
electrophoresis (see Fig. 13) showed that our inhibitor 
preparation is homogeneous with respect to size. 
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Fig. 11. Polyacrylamide gel electrophoretic pattern of 
chymotrypsin inhibitor. 
About 100 /jg of protein was electro-
phoresed in 7% gel for 3 hrs in Tris glycine 
buffer, pH 8.2, { I = 0.02) using a current of 
2 - 5 mA per tube. The gels were stained with 
amidoschwar^i and destained mechanically with 7% 
acetic acid. 
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125 205 285 
Elution volume,ml — ^ 
Fig .12 . Gel chromatography of chymotrypsin inhibitor. 
About 5m g of purified chymotrypsin inhibitor 
obtained by ion exchange chromatography ( peak A 
of Fig. 2) In 3mllOmM sodium phosphate bufferi 
pH 7.5, containinglBOmM NoCl and 0.02V. sodium 
azide was applied on Sephadex G- 200co(umn {2.4 »«78cm) 
which was previously equilibrated with the some buffer. 
The protein was eluted in 5ml fraclions with operating 
buffer at a flow rate of 20ml /h r . The column was 
monitored by the method of Lowry et a l - , (1951). 
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Fig. 13. Sodium dodecyl sulphate polyacrylamide slab gel 
electrophoresis of chymotrypsin inhibitor. 
About 50 jug of the purified chymotrypsin 
inhibitor was electrophoresed on 12% polyacry-
lamide slab gel in the presence of Tris glycine 
buffer ( 25 mM Tris and 194 mM glycine), pH 8.3, 
containing 0.1% SDS for about 3 hrs using a 
current of 2 - 4 mA per lane. The gel was 
stained with coomassie brilliant blue and 
destained mechanically with 10% acetic acid. 
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2. Deteirmination of molecular weight: 
The molecular weight of chymotrypsin inhibitor 
was determined by sodium dodecyl sulphate polyacrylamide 
gel electrophresis in Tris-glycine buffer (25 mM Tris and 
194 mM glycine), pH 8.3, containing 0.1% SDS according to 
the method of Laemmli (1970). 
The marker proteins used including transferrin, 
bovine serum albumin, ovalbumin, Ig G (heavy and light 
chain), chymotrypsinogen A, cytochrome £ and inhibitor were 
electrophoresed in identical conditions. The R of marker 
'^ m 
proteins and inhibitor were determined as the movement of 
protein band relative to the mobility of dye. Here R is 
determined with a maximum error of 6%. The results are 
summarized in Table IX. A plot of log M versus R was 
drawn by the method of least square (see Fig. 14) and the 
straight line obtained fits the equation :--
log M = - 1.39 R + 5.19 (8) 
^ m 
Corresponding to R of 0.26 for chymotrypsin 
inhibitor, the molecular weight of inhibitor was calculated 
with the help of above equation as 68 kDa. The maximum 
uncertainty in the molecular weight determination was 8%. 
The value of molecular weight for chymotrypsin inhibitor 
which we have obtained is in agreement with that reported 
4* 
V ^^y^^f ... 
V 
» » ^ . . _ » ^ • - _ . . ,••• 
-78-
TABLE IX 
LOG M AND R VALUES FOR MARKER PROTEINS AND INHIBITOR 
m 
USED IN SODIUM DODECYL SULPHATE POLYACRYLAMIDE GEL 
ELECTROPHORESIS 
S.N. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
Proteins 
Transferrin 
Bovine serum albumin 
Ig G,heavy chain 
Ovalbumin 
Chymotrypsinogen 
Ig G,light chain 
Cytochrome _£ 
Chymotrypsin 
inhibitor 
A 
Molecular 
Weight 
(kDa) 
76.5^ 
68^ 
51^ 
4-3^  
25.7^ 
25^ 
11.7^ 
-
Log M 
4.8837 
4.8325 
4.7076 
4.6335 
4.4099 
4.3979 
4.0682 
-
R 
m 
0.22 
0.27 
0.33 
0.39 
0.6 
0.57 
0.77 
0.26 
References: Hames (1986) 
Stanworth and Turner (1986 
o 
o 
O.A 0.8. 
R m 
F i g . 14. Plot of R--. values of marker proteins versus 
logarithm of molecular weight. 
The marker proteins were : - ( 1 ) transferrin 
(76.5 kDa), (2 ) bovine serum albumin l68kDa),( 3 ) 
heavy chain of y -. globulin ( 51 kDa), (4) ovalbumin 
lA3kDa),(5) light chain of v-globulin ( 2 5kDa), ( 6 ) 
chymotrypsinogen A {25.7kDa)and ( 7 )cytochrome c 
(11.7 kDa). The R^ ^ of chymotrypsin inhibitor is indicoted 
byan arrow. 
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for alpha-,-antichymotrypsin by Travis et al. , (1978b) but 
slightly higher to that obtained by Laine et al., (1984b). 
3. Optical properties of chymotrypsin inhibitor: 
The concentration of isoionic preparation of 
chymotrypsin inhibitor solution was 1.6 mg/ml and the pH of 
the solution was measured to be 5.5. This cannot be 
compared with the literature value since isoionic pH of 
chymotrypsin inhibitor is being reported for the first time 
in this study. 
The UV absorption spectra of chymotrypsin 
inhibitor in 10 mM sodium phosphate buffer, pH 7.5, 
containing 150 mM sodium chloride is shown in Fig.15. It 
can be seen that maximum absorption occurred near 278 nm. 
Protein solutions of varying concentrations '(0.07-0.15 
mg/ml) were prepared from isoionic preparation of the 
inhibitor and their absorbance were measured at 278 and 280 
nm. The slope of the curve drawn between absorbance and 
protein concentration in g/100 ml, as determined by the 
method of least square analysis, was found to be 6.23 at 
278 nm (see Fig. 16) and 5.92 at 280 nm (see Fig. 17). The 
specific extinction coefficient of human plasma 
alpha-,-antichymotrypsin was determined by Travis et al., 
u 
C 
o 
JQ 
i -
O 
{/) 
< 
270 310 
Wavelength, nm — 
F i g . 1 5. Ultraviolet absorption spectra of chymotrypsin 
inhibitor. 
The solution contains 0.11 mg / ml of the 
inhibitor in 10 mM sodfunn phosphate buffer, 
pH 7.5, containing 1 50 nnM sodium chloride and 
0.02 •/• sodium azide. 
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Fig . 16. Determination of specific extinction coefficient of the 
chymotrypsin inhibitor at 2 78 nm in deionized water. 
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Fig.17. Determination of specitic extinction coetfrcient of chymotrypsln 
inhibitor in deionized water. 
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2 -1 {1978b) to be 6.2 cm g at 280 nm which is only 5% higher 
than that found in this study. 
The excitation and emission spectra of chymotryp-
sin inhibitor were measured in 10 mM sodium phosphate 
buffer, pH 7.5, containing 150 mM sodium chloride at a 
protein concentration of 0.02 mg/ml. The results are shown 
in Fig 18; emission and excitation maxima wore found to be 
338 and 278 nm respectively. These spectral features 
suggest that inhibitor is a tryptophan containing protein. 
4. Chemical analysis: 
i) Carbohydrate content 
The fact that chymotrypsin inhibitor band in 
s odium dodecyl sulphate polyacrylamide gel 
electrophoresis was stainable with periodic acid 
Schiff reagent indicates glycoprotein nature of 
inhibitor. 
Neutral hexose content of the chymotrypsin 
inhibitor was determined by the method of Dubois et 
al., (1956) to be 12% with an experimental error of 
10% . This would corresopond to 46 hexose residues 
per mole of inhibitor. The sialic acid content of the 
inhibitor was determined by the method of Warren 
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(1959) and the value was found to be 4.5% i.e. 10 
sialic acid residues per mole of inhibitor. 
The carbohydrate content of human alpha-,-aritichy-
motrypsin has been determined by different groups (sec 
Table X ) . The reported value for neutral hexose 
content lies between 10-11% i.e. 38-41 residues per 
mole of inhibitor. The sialic acid content of the 
chymotrypsin inhibitor has been reported in the range 
of 4-6% corresponding to 11-14 moles of sialic acid 
per mole of inhibitor. From the results it seems that 
human and goat chymotrypsin inhibitors do not differ 
significantly in neutral hexose and sialic acid 
content. 
ii) Estimation of thiol groups 
The thiol groups present in chymotrypsin 
inhibitor was determined in 10 mM sodium phosphate 
buffer, pH 7.0 and the results are graphically shown 
in Fig. 19 which depicts a plot between increase in 
the absorbance at 250 nm due to reaction of pHMB with 
thiol groups of inhibitor and molar ratio of pHMB to 
inhibitor. The inflection point occurred at pHMB to 
inhibitor molar ratio of one suggesting the presence 
of a single sulfhydryl group per mole of inhibitor. 
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TABLE X 
CARBOHYDRATE COMPOSITION OF CHYMOTRYPSIN INHIBITOR 
Plasma/ Neutral hexose Sialic acid Reference 
Serum Percent moles/ Percent moles/ 
mole mole 
protein protein 
G o a t 
Human 
12 
-
1 0 . 9 
1 0 . 3 
47 
41 
3 8 - 4 
4.5 10 This study 
14 Heimburger 
et al.,(1971) 
11-14 Travis et al .^  
(1978 b) 
4-51 - Laine and 
Hayem (1981) 
o 
U 
c 
o 
xa 
i_ 
o 
< 
[pHMB] 
[ Inhibitor] 
Fig. 19. 
Titrotion of thiol groups of chymotrypsin inhibitor. 
A fixed concentration of inhibitor (A7.2 nM) in lOnnM sodium 
phosphate buffer, pH 7.0. was incubated with increasing concen-
tration of pHMB ( 9,44 nM-131.6 nM) for 6 h r ; the increase in the 
absorbonceat 250 nm wos recorded. 
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However,, after modification of this sulfhydryl group 
with pHMB, no effect on its inhibitory activity was 
found. 
Conflicting reports are available in the 
literature regarding the number of cysteine residues 
in human plasma/serum alpha,-antichymotrypsin. 
Heimburger et al. , (1971) and Laine and Hayem (1981) 
could not detect any cysteine residue by amino acid 
analysis while using the same procedure Travis et al., 
(1978b) found two cysteine residues per mole of 
inhibitor. From the analysis of cDNA for human 
alpha-,-antichymotrypsin Chandra et al. , (1983) deduced 
two cysteine residues per mole of inhibitor. We can 
not compare our results with the literature value as 
we have determined the number of sulfhydryl groups in 
native condition^ therefore, the completely burried 
thiol groups may remain untitrable. 
5. Hydrodynamic properties: 
Hydrodynamic properties of goat chymotrypsin 
inhibitor were determined by analytical gel chromatography 
on a Sephadex G-200 column (2,4 x 78 cm) in 10 mM sodium 
phosphate buffer, pH 7.5, containing 150 mM sodium chloride 
-90-
and 0,02% sodium azide. 
The void volume of the column was determined by 
passing a band of Blue Dextran and the elution profile is 
shown in Fig. 20. The elution volume of Blue Dextran 
which is equal to the void volume of the column was found 
to be 140 ml. The inner volume, V. , was determined by 
passing 0.5% glucose solution. The elution profile is 
shown in Fig. 21 and its elution volume is given by :--
V = V + K, V. (9) 
e, g o d 1 
The- value for distribution coefficient, K,, for 
d 
glucose is 1 and the value of V was calculated to be 
^ e,g 
340 ml. With these values of V , V and K ., , the value of 
e ,g o d 
V. was computed to be 200 ml. The distribution 
coefficient, K, and available distribution coefficient, 
K , for the marker proteins and inhibitor were calculated 
a V 
using the following expressions:-
K^ = ( V^ - V^) / V, (10) 
^av =^  ( ^ e - ^o^ / ^ \ - ^o) (^ 1) 
The total Volume, V , of the column was 
determined to be 353 ml (see experimental section). The 
0.3 
c 
6 
o 
a 0.15-
<D 
O 
C 
o 
Xi 
u 
o (/) 
< 
0.0 - -
U 5 185 
Elution volume, ml — • 
F i g . 2 0 . Elution profile of Blue D«xtran on Sephadex G-200 
column. 
About lOmg of Blu* Dextran wos applied on the 
column equilibrated with lOmM sodium phosphate 
buffer, pH 7.5, containing 150mM sodium chloride 
and 0.0 2 V. sodium azide and eluted in 3 mi fractions 
at a flow rate of 20ml /h r with equilibrating buffer. 
The colour intensity was read at 610 nm. 
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Elution volume, ml 
F i g . 2 1 , Elution profll« of glucose on S«phad«x 6 - 2 0 0 column. 
About 10 mg of gtucos* in 10 mM sodium phosphatt buffer, 
pH 7.5, containing 1 50mM sodium chloride and 0.02 */• sodium 
azide was applied on the column and the carbohydrate was 
eluted in 2 - 5 ml fractions at a flow rate of 20 ml/hr. The 
column was monitored by the method of Dubois et al.^(1956). 
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marker proteins used in gel filtration along with their 
molecular weights and Stokes radii are listed in Table XI. 
The elution profiles of different marker proteins and 
chymotrypsin inhibitor are depicted in Figs. 22-24. The 
elution volume of goat plasma chymotrypsin inhibitor was 
calculated as 202 1.1 ml from the average of four readings. 
For the determination of molecular weight, the 
gel filtration data were analyzed by the method of least 
square using the following expressions:-
V / V = A - B log M (12) 
e o ^ 
1/3 = A - B K ^/3 (13) 
M ^ ^1 "l ^d 
where M is the molecular weight of the inhibitor. 
The linear plots according to equations (12) and (13) are 
depicted in Figs. 25 and 26. The values of V / V , log M, 
K, and M ^ for marker proteins and inhibitor are given in 
Table XII and of constants A, B, A, and B, are given in the 
legends of Figs.25 and 26. The value of V^/V^ of 1.44 for 
chymotrypsin inhibitor corresponds^ according to Fig. 25 to 
a molecular weight of 78 kDa. From a linear plot shown in 
Fig. 26 the molecular weight of the inhibitor was found to 
be 74 kDa. The average molecular weight of chymotrypsin 
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TT^LE XI 
VALUES OF MOLECULAR WEIGHTS AND STOKES RADII OF MARKER 
PROTEINS 
Marker proteins Molecular weight 
(kDa) 
Stokes radius 
(nm) 
BSA dimer 
BSA monomer 
Ovalbumin 
Pepsin 
Chymotrypsinogen 
Cytochrome £ 
- A 
135 
69 
43 
35.5 
25.7 
12.4 
4.3 
3.5 
3.0 
2.29 
2.2 
1.7 
References:— Andrews (1970) 
^ Khan (1982) 
0.3 
E 
c 
o 
o 
u 
c 
o 
o 
< 
0.15 
Bovine serum 
albumin 
Chymotrypsin 
inhibitor 
0 0 
^ ^-y/—» 
180 2 6 0 165 
Elution volume, ml 
2A5 
F i g . 2 2 . Elution profilts of bovint strum albumr n and chymotrypsin 
inhibitor on Sephadex G- 200 column. 
About lOmg of prot«in was applied on Sephadex G - 200 
column(2«A ii78cm) equilibrated with lOmM sodium phosphate 
buffer^ pH7.5^ containing 150 mM sodium chloride and 0.02 '/. 
sodium azide. The protein was eluted in 2 - 5ml fractions 
at a flow rate of 20 ml /hr . The column was monitored by the 
melhod of Lowry et a l . , (1951) . 
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Ovalbumin Pepsin 
V/-
210 250 200 
Elution volunne.ml 
280 
Fig. 23. Elution profiles of ovalbumin and pepsinon3ephadex 
G-200 column. 
The experimental conditions are same as given 
in legend of Fig. 22 . 
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Chymotrypsinogen-A Cytochrome c 
y/-
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Elution volume, ml 
3A0 
F i g . 2 A . Chromatographic prof ilts o'chymotrypsinogtn A and 
cytochromt c on Stphadtx G - 2 0 0 column. 
Th« experimental conditions are same as given 
in legend of Fig- 22 . 
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TABLE XII 
1/3 1/3 
LOG M, V / V , M AND K^ VALUES OF THE MARKER PROTEINS 
e o a 
AND CHYMOTRYPSIN INHIBITOR USED IN GEL FILTRATION EXPERIMENTS 
Proteins V /V Log M K^ "^^  M ' 
e o ^ d 
BSA dimer 
BSA monomer 
Ovalbumin 
Pepsin 
Chymotrypsinogen 
Cytochrome £ 
Chymotrypsin 
A 
Inhibitor 
1.25 
1.46 
1.67 
1.74 
1.85 
2.1 
1.44 
5.1303 
4.8389 
4.6335 
4.5502 
4.4099 
4.0934 
-
0.56 
0.69 
0.78 
0.8 
0.84 
0.92 
0.68 
51.2993 
41.0157 
35.0334 
32.8657 
29.5106 
23.1459 
-
>° 
> ^ 
A.O 44 A.8 
LOQ^QM 
F i g . 2 5- Plot of gel f i l t rat i 'on data according to Andrews (1970) 
The nnarker prote ins used were.-1.BSA dimer, 2.BSA 
monomer, B-ova lbumfn , A . pepsin. 5.chymotr yps'inogen 
A, 6. cy toch rome c. The va lue of V g / V ^ f o r c h y m o t r y -
psin inh ib i tor is shown by an a r r o w . The l inear plot 
obta ined by the method of leas t square f i t s the 
equat ion : . 
Ve / VQ = (Ov82) ( o g ^ ^ + 5-'q5 
- 9 9 -
K > • 
d 
F i g . 2 6. Analysis of gel filtration data according to Porath (19 63) . 
Th» marker proteins used wereM BSA dimer^ 2. BSA monomer, 
3 ovalbumin, 4. pepsin, 5.chymotrypsinogen A, 6. cytochrome c. The 
value of KYS for chymotrypsin I'nhibitor fs shown by an arrov/. The 
straigtvt line computed by the help of least square analysis^ fits the 
equation:- * 
M^''3M'78.1)1) K.^ • 95.03 
» 1 0 0 -
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inhibitor from these two values was calculated as 76 kDa 
which was 12% higher than that obtained by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis. 
The values of K.,, K and other related 
d av 
parameters were calculated for marker proteins and as well 
as for chymotrypsin inhibitor and the results are 
summarized in Table XIII. To determine Stokes radius of 
inhibitor, the gel filtration data were analyzed according 
to Ackers (1967) using the following expression:-
r = 3.64 ( erfc'-'-K,) + 0.93 (14) 
a 
where erfc K, is the error function complement 
of distributioin factor of protein with Stokes radius of r. 
A least square analysis of a plot of erfc K, versus r 
yielded a straight line as shown in Fig. 27. The value of 
erfc K, for chymotrypsin inhibitor was computed to be 0.72 
which according to equation (14) would correspond to a 
Stokes radius of 3.55 nm. 
Another plot was drawn according to Laurent and 
Killander (1964) between Stokes radius and (-log K ) ''^ 
^ av 
and is shown in Fig. 28. The straight line obtained by 
least square analysis fits the following equation:— 
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TABLE XIII 
GEL FILTRATION DATA FOR THE MARKER PROTEINS AND THE 
CHYMOTRYPSIN INHIBITOR ON SEPHADEX G - 200 COLUMN 
Proteins 
BSA dimer 
BSA monomer 
Ovalbumin 
Pepsin 
Chymotrypsinogen 
Cytochrome £ 
Chymotrypsin 
inhibitor 
^d 
0.175 
0.32 
0.47 
0.52 
A 0.595 
0.77 
0.31 
erfc K, 
a 
0,95 
0.7 
0.51 
0.45 
0.38 
0.21 
0.72 
^av 
0.164 
0.301 
0.441 
0.488 
0.559 
0.72 
0.291 
(- log K )^ /2 
^ av 
0.89 
0.72 
0.6 
0.56 
0.5 
0.38 
0.73 
00 
T ) 
O 
u. 
(/) 
o 
• 4 - 1 
F i g . 2 7 . Plot of stokes radius vefsus erfc K^  obtained on a 
Sephadex 6 - 2 0 0 column. 
The marker proteins used were-l. BSA dimer, 2 
BSA m onomer, 3.ovalbumin, ^.pepsin, 5. chymotrypsi-
nogen A,6. cytochrome c. The value of erfc'Kd for chy-
motrypsin inhibitor is indicated by an arrow. 
- 1 0 3 -
0.0 2.5 5.0 
Stokes radius nm * 
Fig. 2 8 Plot of ( -log K y^) 2 values of marker proteins versus 
Stokes radius. 
The- marker proteins used were-.I.BSA dfmer, 2 BSA 
monomer, 3 ovalbumin, 4 pepsin 5 chymotrypsinogen A,6 
cytochromec. The value of (-log KQV)V2 for chymotrypsin 
inhibitor is shown by an arrow. 
- 1 0 4 -
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( - log K )^ = 0.182 r + 0.092 (15) 
^ av 
The value of ( - log K ) of the inhibitor was 
^ av 
determined as 0.73 which according to equation (15) would 
give the value of 3.51 nm for the Stokes radius of the 
inhibitor. 
From the knowledge of Stokes radius diffusion 
coefficient/ D, of the inhibitor was calculated with the 
help of following expression ( Andrews, 1970):--
D = k T / 6 T T r j r (16) 
Where k is the Boltzmann constant, i1 is the 
coefficient of viscosity of the medium (i.e. 10 mM sodium 
phosphate buffer, pH 7.5, containing 150 mM sodium 
chloride) and T is the absolute temperature. With k -
1.386 X lO"-""^  ergs/degree; i^  = 0.01 poise; T = 302^ K and 
i_he determined value of Stokes radius, the value of 
diffusion coefficient for the inhibitor was calculated as 
-7 2 6.29 X 10 cm /sec. 
The frictional ratio, f/f , of the inhibitor was 
calculated using the relation (Siegel and Monty, 1966):--
f/f = r/(3 V2 M/4 r\- N ) ' ^ ^ ^ (17) 
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23 
where N is Avogadro' s number ( 6.023 x 10 per 
mole) and v- is the partial specific volume of protein in 
ml/g . The partial specific volume of goat chymotrypsin 
inhibitor was taken to be 0.715 ml/g. , same as that of 
human alpha-, -antichymotrypsin calculated from amino acid 
and carbohydrate composition ( Travis et al. , 1978b). The 
molecular weight of inhibitor was taken as 68 kDa as 
determined by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis. Using these values, the frictional ratio 
for chymotrypsin inhibitor was calculated as 1.32 with the 
help of equation (17). 
6. Functional properties: 
The activity of chymotrypsin inhibitor was 
measured against both chymotrypsin and trypsin in 10 mM 
sodium phosphate buffer, pH 7.5, containing 150 mM sodium 
chloride. It was found to inhibit both the enzymes, 
however, inhibition was found to be more pronounced for 
chymotrypsin than trypsin. 
Chymotrypsin was first passed on a Sephadex G -
200 column to enrich the preparation and then it was 
treated with TLCK. On treatment with TLCK 10% of the total 
enzyme activity was reduced which may be due to the 
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contamination of trypsin in our chymotrypsin preparation. 
The TLCK treated chymotrypsin was then taken for further 
studies . 
The stoichiom etry of the reaction between 
chymotrysin/trypsin and inhibitor was determined by 
treating a constant amount of enzyme with varying 
concentrations of inhibitor and the results are summarized 
in Figs. 29 and 30. Evidently complete inhibition of chymo-
trypsin was achieved at an inhibitor to enzyme molar ratio 
of 1.1 (see Fig. 29), however, this ratio increased to 4.54 
for trypsin. 
For studies on the time course of inactivation of 
chymotrypsin by the goat chymotrypsin inhibitor, an 
aliquot of 1 ml sample was drawn at different time 
intervals from an enzyme and inhibitor mixture and its 
residual caseinolytic activity measured. The results on 
the inactivation of chymotrypsin and trypsin are 
respectively shown in Figs. 31 and 32, where it can be seen 
that the inhibition of chymotrypsin was completed within 5 
minutes. In contrast, the inhibition of trypsin by goat 
chymotrypsin inhibitor was a slow process and required 
about 50 minutes to achieve complete inhibition. It is, thus 
clear that the inhibitor abolished the chymotryptic 
100 
> 
u 
o 
E 
N 
C 
<x> 
D 
'w 
50 -
0 -
1 
[inhibitor] 
[Chymotryps'in] 
Fig. 29. Eff»ct of inhibitor conctntratfon on its activity. 
Th» enzymt, chymotrypsin (A.35 "ID mW)was incubated 
with difftrerent concentration of chymotrypsin inhibitor 
( A.35X 10"^ mM to6.7 -lO'^ nriM) for 20 minutes at 37 *C. The 
residual enzyme activity was nieasured according to the 
method of Anson (1938) using casein as substrate. 
_ i n R _ 
[Inhibitor ] 
[Trypsin] 
F i g . 3 0 . Inhibition of trypsin by chymotrypsin inhibitor. 
incrtosing omount of chymotrypsin inhibitor (A-29 «10~^mM 
to 3 «tO"5nnM)wtrf added to constant amounts of trypsin 
(429 .10-6 mM) and incubated for 50 minutts at 37*C The rtsfdual 
»n2yme activity was measured using casein as substrate. 
- 1 0 9 -
u 
O 
N 
c 
Of 
o 
X) 
(/) 
o 
100 
0 20 40 60 
Time. mm. 
Fig. 31 A plot of re$idual enzyme activity as a function of 
incubation time of chymotrypsin / chymo trypsin inhibitor 
mixture. 
Residual enzyme activity was measured on aliquots 
withdrawn at different time intervalsfroma.mixture of 
inhibltor/chymotrypsin (molar ratio 1:1) kept at 37*C. 
The residual enzyme activity was measured using casein 
as substrate. 
- 1 1 0 -
t 
100 
(J 
o 
Of 
E 
N 
C 
0) 
"o 
30 60 
T i m e, m i n 
F i 9 . 3 2 . Residual cnzymt octivrty versus incubation time 
of chymoirypsin inhibitor wrth trypsin. 
Residual enzyme activity was measured on aliquots 
withdrawn at different time intervals from a mixture 
of inhibitor and enzyme (mo la r ratio 5-.1) kept at 37*0 
for 50 minutes. The residual enzyme activity was measured 
using casein as substrate. 
- H I -
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activity in a biologically feasible time. It is, therefore, 
possible to analyse results of Fig. 31 with the help of the 
following expression (Beith, 1980):--
1/[E] = k t + 1/[E] (18) 
'- ^ ass o 
where [E] is the enzyme concentration at time 
zero, [E] is the enzyme concentration at any time, t. The 
basic assumption involving the above expression is that the 
inhibition should be irreversible one for which the only 
relevant rate constant will be k . This is likely to be 
ass ^ 
true because most of the plasma proteinase inhibitors are 
proteolytically modified upon reaction with proteinases 
(Laine et al., 1982a) and the resultant inhibitor enzyme 
complexes are usually highly stable (Travis and 
Salvesen,1983). Secondly, the enzyme and the inhibitor 
should be in equal concentrations. 
A plot of 1/[E] versus t should be linear 
according to equation (18). The value of [E] was 
determined from the dependence of caseinolytic activity on 
total enzyme concentration. Such a plot was obtained from 
the data of Fig. 31 by the method of least square and is 
shown in Fig. 33. From the slope of the linear plot, the 
O 
LU 
0.5 
0.25 
0.0 
0 150 
Time, sec. 
300 
F i g . 3 3 . Th« second order plot of time dependency of the 
inhibition of chymotrypsin by goal chymotrypsln 
inhibitor in accordance with equation (18 ) . 
- 1 1 3 -
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rate constant of association of the inhibitor with the 
4 -1 -1 
enzyme i.e. k was calculat e4 to be 1.6 x 10 M s 
u. o o 
The interaction of human alpha,-antichymotrypsin with human 
and bovine chymotrypsin.has been studied ( Beatty et al. , 
4 -1 -1 1980) and the reported value ( 1 - 6 x 10 M s ) wds 
found to be comparable to the one obtained in this study. 
7. Effect of heat treatment on antichymotryptic activity 
of chymotrypsin inhibitor: 
Goat chymotrypsin inhibitor was heated at 45 C, 
50 C , 55 C and 60 C for 15 minutes in 10 mM sodium 
phosphate buffer, pH 7.5, containing 150 mM sodium 
chloride. No insoluble protein was visible in the 
solution. The decrease in the inhibitory activity of the 
goat chymotrypsin inhibitor at different temperatures is 
depicted in Fig. 34. The chymotrypsin inhibitor treated at 
45 C retained the same inhibitory activity as that of 
native inhibitor. When the inhibitor was heated at 50°C 
and 55 C, the losses in inhibitory activity at these 
temperatures were found to be 35% and 65% respectively. 
The inhibitor completely lost its activity when heated at 
60 C . It is noteworthy that the human 
alpha,-antichymotrypsin was reported to be stable upto 50 C 
1 OO 
o 
o 
E 
N 
C 
a 
to 
Inhibitor concentration.mg — • 
r i g . 3A. Ef fect of heat treatment on the activity of chymolrypsin 
inhibitor. 
A fixed concentration of chymotrypsin (4.29 * 10 mM) 
and an indicated concentration of native inhibitor ( - O O- ) 
or inhibitor which was heated at A5*C (—• • — ) , 50*C 
(~^—A-) , 5 5*0 (—O O-)and60*C ( - Q — • - ) was incubated 
at 37 C for 30 minutes. The residual enzyme activity was 
measured using casein as substrate as described in the text • 
- 1 1 5 -
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while the activity was reduced to half when it was heated 
at 55°C for 15 minutes and 60 C treated inhibitor 
completely lost its activity (Matsumoto et al. , 1982b; 
Tsuda et al., 1986) . 
DISCUSSION 
Chymotrypsin inhibitor was isolated both from 
goat plasma and serum by ammonium sulphate fractionation 
at pH 4.5 followed by purification by ion exchange 
chromatography. Interestingly, the inhibitor thus 
isolated was found to be free from extrenous proteins as 
judged by single coomassie stainable protein band in 
sodium dodecyl sulphate polyacrylamide gel ele::trophoresis 
in Tris glycine buffer { 25 mM Tris and 194 mM glycine), 
pH 8.3. Salt fractionation at pH 4.5 resulted in the 
removal of major plasma protein viz, albumin which could 
not be removed to the desired extent when ammonium 
sulphate fractionation was carried out at pH 7 . 0 . in this 
respect, the present procedure differs from other methods 
used earlier for the isolation of alpha-,-antichymotrypsin 
from human plasma/serum (Travis et al. , 1978b; Siddiqui 
et al., 1980; Abdullah et al., 1983; Laine et al., 1984b) 
In previous methods after salt fractionation usually more 
than one step of purification was required for isolating 
human plasma alpha-, -antichymotrypsin of comparable purity 
(Travis et al., 1978b; Abdullah et al., 1983). Further, 
unlike the procedure used by Laine et al. , (1984b) in 
which human serum alpha-, -antichymotrypsin was exposed to 
-117-
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pH 2.8 during isolation, the present method does not 
involve the exposure of goat chymotrypsin inhibitor to pH 
less than 4.5. This is important in view of the notable 
observation made by Travis et al., (1978a) who found that 
the human alpha-,-antichymotrypsin was 80% inactivated 
when exposed to pH 3.0 for 5 minutes. 
Goat chymotrypsin inhibitor in this study was 
found to be a sialoglycoprotein containing 12% neutral 
hexose and 4.5% sialic acid residues. This would 
correspond to 47 moles of neutral hexose and 10 moles of 
sialic acid residues per mole of inhibitor; the molecular 
weight used in the calculation was 68 kDa. For human 
alpha,-antichymotrypsin Heimburger et al., (1971) and 
later Travis et al., (1978b) found 38-41 neutral hexose 
and 11-14 sialic acid residues per mole of protein. 
However, Laine and Hayem (1981) reported that both human 
serum and pleural fluid inhibitors have same amount of 
neutral hexoses and sialic acid residues; the values 
being 35 and 10 residues respectively per mole of 
inhibitor. In contrast to these inhibitors, chymotrypsin 
inhibitor isolated from other sources such as marine 
turtle egg white (Guha and Sinha, 1984) and silkworm 
larval hemolymph (Sasaki, 1985) do not contain any 
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carbohydrate. This observation is noteworthy since 
survival of the inhibitor in the serum depends on the 
carbohydrate content as it was found that half life of 
rat alpha,-proteinase inhibitor without carbohydrate is 
six times less than that for the inhibitor with 
carbohydrate (Weber et al., 1985). 
The inhibitor under native state contains one 
free sulfhydryl group which is available for the reaction 
with p-hydroxymercuribenzoate. However, the fact 
that the treatment with p-hydroxymercuribenzoate did not 
abolish the activity of goat chymotrypsin inhibitor, 
excludes any functional role for the lone sulfhydryl 
group of the inhibitor. Such studies have not been 
carried out for other inhibitors. It will be, therefore, 
interesting to determine free sulfhydryl group of 
chymotrypsin inhibitor present in other mammalian serum 
including human serum. 
The molecular weight of goat chymotrypsin 
inhibitor was determined by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis to be 68 kDa both 
under reducing and non-reducing conditions suggesting 
that inhibitor is a single chain protein molecule. 
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Similar values ( 64-68 kDa ) were reported for human 
alpha-, -antichymotrypsin both by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis ( Travis et al., 
1978b; Siddiqui et al., 1980) and sedimentation 
equilibrium (Travis et al. , 1978b; Katsunuma et al. , 
1980). Since the goat chymotrypsin inhibitor has been 
found to be a sialoglycoprotein containing 17% 
carbohydrate, the molecular weight estimated by gel 
filtration is expectedly higher i.e. 76 kDa. This 
observation is in agreement with the results obtained in 
this laboratory by Waheed and Salahuddin (1975). After 
exclusion of carbohydrate moieties, the molecular weight 
of human alpha,-antichymotrypsin was calculated to be 44 
kDa (Matsumoto et al., 1982b; Chandra et al., 1983) which 
is identical to that (43 kDa) determined for chymotrypsin 
inhibitor isolated from silkworm larval hemolymph 
(Sasaki, 1985). It will be, therefore, interesting to 
find out structural differences between silkworm larval 
hemolymph chymotrypsin inhibitor and mammalian 
inhibitor. However chymotrypsin inhibitor 
olated from other sources such as ascaris (Babin et 
•12] 
al., 1984), snake venom (Ritonja, 1983b) and marine 
turtle egg white (Guha and Sinha, 1984) are usually low 
molecular weight proteins ranging between 7-13 kDa. Here 
it should be pointed out that by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis Laine and Hayera (1981) 
obtained significantly lower value (58 kDa) for molecular 
weight of human alpha,-antichymotrypsin isolated from 
pleural fluid. It seemed that inhibitor in pleural fluid 
might be destroyed by some proteases but they have 
obtained the same results also for serum 
alpha-,-antichymotrypsin (Laine and Hayem, 1981; Laine et 
al., 1984b). Thus this may be either due to different 
calibrations and conditions used in sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (Laine and 
Hayem, 1981) or due to exposure of inhibitor to acidic pH 
(Berninger, 1985). 
The isoionic pH of the goat inhibitor has been 
found in this study to be 5.5 at a protein concentration 
of 1.6%. The corresponding value for human 
alpha,-antichymotrypsin is not available. However, thin-
layer polyacrylamide gel isoelectric focussing of human 
alpha,-antichymotrypsin showed seven bands with isoelec-
tric points at pH values of 4.1. 4.15, 4.2, 4.26, 4.32, 
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4.38 and 4.45. The microheterogeneity of 
alpha-,-antichymortypsin persisted even after removal of 
sialic acid by neuraminidase treatment. The different 
isotypes of human alpha,-antichymortypsin persisted even 
after removal of sialic acid by neuraminidase treatment. 
The different isotypes of human alpha-,-antichymotrypsin 
interacted normally with chymotrypsin ( Gianazza and 
Arnaud, 1981). The ultra-violet light absorption spectra 
of chymotrypsin inhibitor studied in 10 mM sodium 
phosphate buffer, pH 7.5, containing 150 mM sodium 
chloride, showed maximum absorption near 278 nm where the 
specific extinction coefficient was determined to be 6.23 
2-1 . . 
cm g ; the value of specific extinction coefficient at 
2 -1 280 nm was 5.92 cm g . The value of specific 
extinction coefficient at 280 nm is similar to that 
2 -1 (6.2 cm g ) measured for human alpha-,-antichymotrypsin 
(Travis et al., 1978b). Available data on human 
alpha-,-antichymotrypsin showed the presence of 3-4 
tryptophan residues, 9-10 tyrosine residues and 24-26 
phenylalanine residues per mole of inhibitor (Heimburger 
et al., 1971; Travis et al., 1978b; Chandra et al., 1983) 
In view of these considerations it seems that goat 
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chymotrypsin inhibitor is- also a tryptophan containing 
protein. This contention finds further support from the 
study of excitation and emission spectra of inhbitor 
under native conditions (Fig.18), where it can be seen 
that fluorescence emissioin for the inhibitor was maximum 
at 338 nm; the wavelength of excitation was 278 nm. 
The gel filtration behaviour of goat 
chymotrypsin inhibitor was studied on Sephadex G-200 
column and its Stokes radius was determined as 3.53 nm. 
-7 2 The diffusion coefficient ( 6.29 x 10 cm /sec.) and 
frictional ratio, f/f (1.37) determined for the 
inhibitor showed that goat chymotrypsin inhibitor 
possesses a nonglobular conformation. Alternatively the 
hydrodynamic data particularly the deviation of f/f from 
unity can be interperated in terms of unusual 'high 
hydration of the inhibitor. It appears to be a real 
possibility in view of the fact that the inhibitor 
conotains 17% carbohydrate which would extensively 
interact with water molecules. 
Results presented on the functional properties 
of goat chymotrypsin inhibitor in this thesis showed that 
goat inhibitor is an effective inhibitor of chymotrypsin 
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and abolishes all chymotryptic activity at a molar ratio 
of enzyme to inhibitor of 1.1. The inactivation at this 
molar ratio was rather rapid. However, it showed weak 
inhibitory activity against trypsin. The inhibition of 
tryptic activity was slow and required substantially 
higher inhibitor concentration ([1]/[E] = 4.5) for 
achieving complete inhibition. Our results also suggest 
that association constant, k , for inhibitor-chymotryp-
ass 
4 -1 -1 
s m system is about 1.57 x 10 M s . Further goat 
chymotrypsin inhibitor shows significant thermal 
stability. It retains almost all inhibitory activity 
upon heating at 45°C. However, heat treatment above 
45°C resulted in the loss of activity. It is interesting 
to note that the values of k for the interaction of 
ass 
human alpha,-antichymotrypsin with human chymotrypsin 
4 4 
( 1.0 X 10 ) and bovine chymotrypsin ( 6^ 0 x 10 ) were 
4 
similar within experimental error with that (1.5 x 10 ) 
determined in this study (Beatty et al., 1980). The 
thermal stability of human alpha,-antichymotrypsin was 
also found to be similar (Matsumoto et al., 1982b; Tsuda 
et al., 1986). Strikingly, human alpha,-antichymotrypsin 
did not show any detectable activity against trypsin 
(Travis et al., 1983a). In contrast goat chymotrypsin 
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inhibitor showed measurable although weak antitryptic 
activity. In conclusion our results showed that the goat 
chymotrypsin inhibitor is not identical to human plasma/ 
serum alpha-,-antichymotrypsin. 
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